Multifunctional composite microgels: From structural design to biomedical applications Authors: Yanli Cai, Dong Xu, Zi En Chong, Elaine Shi An Chen, Soo Wah Gan, Alvin Shu Kiat Bok, Wen Feng Lu, Wei Zhai, Ching-Chiuan Yen Published: 2026 ABSTRACT Microgels, micrometer-sized hydrogel particles, have emerged as versatile platforms for biomedical applications. Recent advances have driven the development of composite microgels that integrate polymers, nanomaterials, and bioactive agents to achieve precise control over their properties. In this review, we provide a comprehensive overview by establishing a systematic framework that links the structural design to the mechanisms of cell regulation, and ultimately to biomedical applications. We examine how composite microgels regulate cells by their intrinsic material cues, including the mechanical, biochemical, and architectural properties, as well as by dynamic mechanisms, such as on-demand stimuli-responsiveness and autonomous pre-programmed kinetics. We then illustrate how these principles are applied across cancer therapy, tissue engineering, and regenerative medicine. Finally, we discuss key challenges of scalability, biosafety, and clinical integration, and outline future perspectives, such as the role of AI-driven design, in advancing personalized medicine and regenerative therapies. Introduction Hydrogels have long been recognized as valuable materials in biomedical applications due to their ability to mimic the extracellular matrix (ECM), high water content, biocompatibility, and tunable properties [[1], [2], [3]]. They have been applied in areas such as drug delivery [4], tissue engineering [[5], [6], [7], [8]], cancer therapy [9], bioelectronics [10], where their versatility enables creative and impactful solutions. However, as the demands of modern biomedicine evolve, conventional bulk hydrogels face inherent limitations. Their restricted injectability hinders minimally invasive delivery, while their monolithic nature makes it difficult to achieve the spatiotemporal control, dynamic responsiveness, and multifunctional architectures to address complex biomedical challenges. Microgels, micrometer-sized hydrogel particles, have emerged as a promising solution. These colloidal systems retain the intrinsic properties of bulk hydrogels, yet their particulate form provides crucial advantages in modularity and versatility. Unlike bulk hydrogels, microgels create protective, ECM-like niches that safeguard encapsulated cells, enhance oxygen and nutrient exchange, and promote their subsequent integration into host tissues [1,[11], [12], [13], [14], [15]]. In addition, their shear-thinning properties and injectable characteristics allow their use as granular bioinks to improve biological functions of 3D printed scaffolds [16,17]. With tunable size and architecture, they also serve as highly effective carriers for targeted and controlled drug delivery [18,19]. The capabilities of microgels are markedly expanded when they are designed as composite microgels, formed by integrating two or more distinct materials. This multi-material approach enables the engineering of properties like multi-stimuli responsiveness and precise spatiotemporal control over the distribution and release of bioactive agents that are difficult to achieve in single-component microgels. This is often realized through innovative structural designs, such as spherical [[20], [21], [22]], core-shell [23], hollow [24], Janus [25], crescent [26], rod-shaped [27], and multicompartment structures [28]. These architectures facilitate precision drug delivery [29,30], allow for sequential or orthogonal release of biomolecules [25], support advanced cancer therapies [[31], [32], [33]], and enhance tissue regeneration [[34], [35], [36]]. The remarkable potential of composite microgels highlights the need for a comprehensive review that compiles current knowledge and emerging directions in this rapidly evolving field. While existing reviews have provided valuable summaries on specific materials [37], fabrication methods [38], shapes [39], or applications [40,41] within the broader field of microgels, a comparative framework that explicitly articulates the key linkages and design trade-offs is still lacking. Here, we address this gap by presenting a trade-off-aware, function-driven framework that connects structural design to mechanisms of cell regulation and, ultimately, to biomedical applications (Fig. 1), while critically considering the clinical constraints that shape translational feasibility. To build this framework, it is first necessary to define our scope. The terminology and size range for “microgels” are notably inconsistent in the literature, with definitions spanning from approximately 100 nm to several micrometers [42], or 100 nm to 10 μm [43]. In this review, we focus on composite microgels within a size range of approximately 100 nm to 1000 μm. This scope is intentionally chosen to be comprehensive, including systems from the nanogel-to-microgel transition zone (∼100 nm) that are critical for drug delivery via the enhanced permeability and retention effect [30]. The upper bound (1000 μm) then encompasses the larger particles used for applications like islet encapsulation [44] or as the modular building blocks for granular scaffolds, which distinguishes our focus from monolithic bulk hydrogels. Specifically, we first outline a function-driven design pathway from composition and crosslinking to architecture and tissue-scale assembly. We then detail how these engineered properties translate into cell regulatory mechanisms, both through stable intrinsic cues and dynamic stimuli-responsive or pre-programmed kinetics. These principles are then illustrated across cancer therapy, tissue engineering, and regenerative medicine. Finally, we discuss key challenges of scalability, biosafety, and clinical integration using critical quality attributes (CQAs) as an organizing framework, and outline future perspectives including AI-driven design, to provide a roadmap for translating composite microgels from laboratory platforms into clinical reality.Fig. 1Schematic illustration of structurally engineered composite microgels regulating cell behaviors for biomedical applications. Schematic illustration of structurally engineered composite microgels regulating cell behaviors for biomedical applications. Design strategies for multifunctional composite microgels Composite microgels are hydrogel-based colloidal particles that integrate diverse components, such as natural and synthetic polymers, nanoparticles (NPs), nanofibers (NFs), drugs, and other bioactive agents, within a single microstructure. Their functional performance emerges from structural organization across multiple scales. Here we outline a function-driven design pathway covering compositional and crosslinking strategies for tuning intrinsic properties, fabrication trade-offs that shape microgel architectures, and assembly of microgels into tissue-scale constructs. Engineering composition and crosslinking for tunable properties The design of a composite microgel begins with engineering its material composition and crosslinking strategy, which together determine key tunable properties from mechanical stiffness to physicochemical behavior. Composition design involves selecting materials from a broad toolbox (Table 1). Natural polymers such as gelatin (Gel) and hyaluronic acid (HA) provide intrinsic biocompatibility and cell-adhesive motifs, whereas synthetic polymers such as poly(ethylene glycol) (PEG) and poly(N-isopropylacrylamide) (PNIPAM) offer greater control over mechanical properties and stimuli-responsiveness. By blending these materials, composite designs can partially decouple mechanical tuning from biochemical signaling. Functional components are then incorporated to address specific clinical needs. For instance, silver NPs (AgNPs) provide antimicrobial activity [56], while gold nanoparticles (AuNPs) or superparamagnetic iron oxide NPs (SPIONs) enable external control for photothermal therapy [57] or targeted localization [60]. Bioactive agents such as vascular endothelial growth factor (VEGF) can further promote angiogenesis and guide tissue regeneration [25]. However, adding nanomaterials creates a critical translational trade-off that long-term biosafety and clearance must be justified by meaningful therapeutic benefit.Table 1Building blocks for engineering composite microgel functionality.Table 1Component categoryClassification & examplesFunctional contributions to composite microgelCommon application areasReferencesPolymersNatural polymers (e.g., gelatin, HA, alginate, chitosan, agarose)Structural integrity, biocompatibility, bioactivity, ionic crosslinking sitesTissue regeneration, cell delivery, wound healing, 3D bioprinting, drug evaluation[15,[45], [46], [47], [48]]Functionalized natural polymers (e.g., GelMA, HAMA, Alg-NB)Intrinsic bioactivity and biocompatibility, tunable network properties from the addition of covalent crosslinking sites3D bioprinting, organ-on-chip, tissue engineering and regenerative medicine[[49], [50], [51], [52]]Synthetic polymers (e.g., PEG, PNIPAM, PAA)High tunability, bioinertness (antifouling), stimuli-responsiveness (e.g., temperature, pH)Antifouling surfaces, protein detection, stimuli-responsive drug delivery, wound healing[29,[53], [54], [55]]NanomaterialsMetallic NPs (e.g., AuNPs, AgNPs, Gallium-based liquid metal NPs)Photothermal response, antimicrobial activity, electrical conductivityCancer therapy, wound healing, biosensing[[56], [57], [58], [59]]Magnetic NPs (e.g., SPIONs, Fe3O4 NPs)Magnetic responsiveness (for targeting, hyperthermia), MRI contrastCancer therapy, diagnostics[60,61]Ceramic NPs (e.g., HAp, BG, Laponite)Osteoconductivity, mineralization, ion releaseBone tissue engineering[36,62,63]Carbon-based NPs (e.g., graphene oxide, graphene quantum dot)Electrical conductivity, mechanical reinforcement, fluorescent labelingBioelectronics, diagnostics, tissue engineering[64,65]Nanofibers (e.g. PLA NFs, cellulose NFs)Mechanical reinforcementCell modulation[66,67]Bioactive agentsDrugs (e.g., DOX, curcumin, cisplatin)Chemotherapeutic effectCancer therapy[60,68,69]Protein-based agents (e.g., VEGF, BMP2, antibodies)Angiogenic/osteogenic signaling, therapeutic targeting, immunomodulationCancer therapy, tissue engineering and regenerative medicine[25,70,71]Nucleic acids (e.g., siRNA, miRNA)Gene silencing, protein expressionCell therapy, tissue engineering and regenerative medicine[72,73] Table 1Building blocks for engineering composite microgel functionality.Table 1Component categoryClassification & examplesFunctional contributions to composite microgelCommon application areasReferencesPolymersNatural polymers (e.g., gelatin, HA, alginate, chitosan, agarose)Structural integrity, biocompatibility, bioactivity, ionic crosslinking sitesTissue regeneration, cell delivery, wound healing, 3D bioprinting, drug evaluation[15,[45], [46], [47], [48]]Functionalized natural polymers (e.g., GelMA, HAMA, Alg-NB)Intrinsic bioactivity and biocompatibility, tunable network properties from the addition of covalent crosslinking sites3D bioprinting, organ-on-chip, tissue engineering and regenerative medicine[[49], [50], [51], [52]]Synthetic polymers (e.g., PEG, PNIPAM, PAA)High tunability, bioinertness (antifouling), stimuli-responsiveness (e.g., temperature, pH)Antifouling surfaces, protein detection, stimuli-responsive drug delivery, wound healing[29,[53], [54], [55]]NanomaterialsMetallic NPs (e.g., AuNPs, AgNPs, Gallium-based liquid metal NPs)Photothermal response, antimicrobial activity, electrical conductivityCancer therapy, wound healing, biosensing[[56], [57], [58], [59]]Magnetic NPs (e.g., SPIONs, Fe3O4 NPs)Magnetic responsiveness (for targeting, hyperthermia), MRI contrastCancer therapy, diagnostics[60,61]Ceramic NPs (e.g., HAp, BG, Laponite)Osteoconductivity, mineralization, ion releaseBone tissue engineering[36,62,63]Carbon-based NPs (e.g., graphene oxide, graphene quantum dot)Electrical conductivity, mechanical reinforcement, fluorescent labelingBioelectronics, diagnostics, tissue engineering[64,65]Nanofibers (e.g. PLA NFs, cellulose NFs)Mechanical reinforcementCell modulation[66,67]Bioactive agentsDrugs (e.g., DOX, curcumin, cisplatin)Chemotherapeutic effectCancer therapy[60,68,69]Protein-based agents (e.g., VEGF, BMP2, antibodies)Angiogenic/osteogenic signaling, therapeutic targeting, immunomodulationCancer therapy, tissue engineering and regenerative medicine[25,70,71]Nucleic acids (e.g., siRNA, miRNA)Gene silencing, protein expressionCell therapy, tissue engineering and regenerative medicine[72,73] Building blocks for engineering composite microgel functionality. The crosslinking strategy dictates the stability and adaptability of microgel network, creating a key design trade-off between injectability and long-term durability. Physical and chemical crosslinking are two basic approaches [74]. Physical crosslinking relies on reversible, non-covalent interactions, such as ionic bonding between alginate and calcium ions (Alg-Ca2+) [15,75,76], electrostatic interactions between positively charged chitosan and negatively charged alginate (CS-Alg) [77], or hydrogen bonds between hydroxyl groups in exopolysaccharide and phosphoryl groups in sodium tripolyphosphate [78]. These reversible networks can be self-healing and shear-thinning, making them well suited for injectable cell delivery; however, they often exhibit limited mechanical stability under physiological conditions. By contrast, chemical crosslinking forms permanent covalent networks via photopolymerization (e.g., in situ UV crosslinking of gelatin methacrylate and hyaluronic acid methacrylate (GelMA/HAMA) microgels [49]), enzymatic crosslinking (e.g., transglutaminase-crosslinked gelatin microgels [79]), or Michael addition (e.g., rapid and spontaneous crosslinking between thiolated Gel (Gel-SH) and ethylsulfated HA (HA-VS) [80]). These covalent networks are typically more robust and are therefore suitable for load-bearing scaffolds. However, they reduce dynamic adaptability (e.g., stress relaxation) that cells often require for spreading and may involve potentially cytotoxic reagents. Crucially, interfacial interactions between components translate material selection into functional performance. Polymer-nanomaterial interactions range from simple physical entrapment to covalent bonding. For example, non-covalent electrostatic interactions between heterogeneously charged Laponite NPs and GelMA chains create rough, porous surfaces that promote cell adhesion and spreading [81]. In contrast, covalent anchoring, such as bonding between methacrylated cellulose NFs and acrylamide monomers, improves long-term mechanical stability, although it may reduce swelling capacity [66]. Likewise, polymer-bioactive agent interactions govern the encapsulation and release of drugs or growth factors (GFs). Strong covalent conjugation immobilizes bioactive agents directly to hydrophilic polymers, or via cleavable, stimuli-responsive linkers, enabling stable or triggered release [82]. Weaker electrostatic interactions, such as those between positively charged VEGF and negatively charged GelMA/HAMA, can be tuned to achieve sustained release profiles [83]. By jointly engineering composition and crosslinking, composite microgels can be tuned across mechanical properties, degradation, and biofunctionality as cell-instructive matrices. This foundational chemistry also constrains downstream fabrication, because polymer reactivity and interfacial bonding determine which processing methods are feasible and which architectures can be reliably formed. The next section therefore summarizes how these engineered materials are processed to generate architectures ranging from homogeneous spheres to complex multicompartment microgels. Fabricating diverse architectures for spatiotemporal control Having established the foundational properties of the microgel network, the next design step is to shape these materials into defined microstructures. Architectural engineering is central to spatiotemporal control, as microgel geometry and compartmentalization dictate how the particle interacts with its environment and where it exerts its function. This stage is governed by a three-way trade-off among particle uniformity, production throughput, and process complexity. For homogeneous spheres, this balance often determines whether microfluidic precision or emulsion-based scalability is preferred; for heterogeneous multicompartment structures, it dictates whether spatial fidelity or production volume takes priority. As the technical details and engineering considerations of these fabrication platforms have been comprehensively reviewed elsewhere [40,[84], [85], [86]], this section focuses on how they are used to generate specific architectures and on the resulting trade-offs in complexity, controllability, and clinical feasibility. Table 2 provides a comparative framework by summarizing key features, common fabrication methods, and major translational challenges for homogeneous and heterogeneous composite microgels.Table 2Comparison of architectures of composite microgels.Table 2CategoryStructureKey featuresCommon fabrication methodsAdvantagesDisadvantages & challengesTypical applicationsHomogeneousSphereIsotropic geometry with uniform compositionWater-in-oil emulsion [36,62]Simple fabrication; predictable physicochemical propertiesLimited functionality; no spatial control over nanomaterials, bioactive agents or cell organizationDrug delivery with defined release profiles [87], cell encapsulation for reproducible tissue regeneration [70,88], wound healing [56]Emulsion polymerization [69,89]Precipitation polymerization [55,56]Microfluidics [87,88]Microfluidic electrospray [35,70]Gas shearing [28]Polygon/StarAnisotropic shape with sharp vertices and defined edgesMolding [90]Sharp features transmit shear forces or act as sites of focal mechanical stress to influence cellsPoor injectability due to irregular packing; sharp corners may cause mechanical failure or induce a stronger inflammatory responseCell delivery platforms requiring tissue penetration [90]DLP [91]RodHigh aspect ratio providing directional cuesMolding [27]Provides topographical cues to guide cell alignment and directional migrationCan be difficult to inject without breakingGuided regeneration of aligned tissues [27], vascular engineering [92]Microfluidics [92]HeterogeneousCore-shellA concentric architecture comprising an inner core and an outer shellEmulsion [68]Protects sensitive components (cells, bioactive agenst); enables temporal control of cell behaviorFabrication complexity; risk of premature “burst release” or shell ruptureCell delivery [93], drug delivery [15,68]Microfluidics [94,95]Microfluidic electrospray [15,93]Layer-by-layer assembly [96]HollowAn empty internal cavity surrounded by a solid shellSacrificial template method [97,98]Maximizes loading capacity; provides a large, protected void for cell cultureShell integrity is critical to prevent collapse; can be difficult to load post-fabricationDrug delivery [98], non-invasive cell delivery and culture [24,99]Microfluidics [24,99]JanusTwo distinct hemispheres joined at a single interface, creating anisotropyMicrofluidic electrospray [25,100]Provides dual functionality and directional propertiesInterface stability can be a mechanical weak point; requires precise fluid stream alignmentSequential drug release [25]Gas shearing [28]PPAP [101]MulticompartmentMultiple (>2) physically distinct domains within a single microgelGas shearing [28]Allows simultaneous delivery of multiple, incompatible agents and co-culture of different cell typesHighest fabrication complexity; precise control over compartment size and position is difficultMulti-cellular microtissues [29]PPAP [101] Table 2Comparison of architectures of composite microgels.Table 2CategoryStructureKey featuresCommon fabrication methodsAdvantagesDisadvantages & challengesTypical applicationsHomogeneousSphereIsotropic geometry with uniform compositionWater-in-oil emulsion [36,62]Simple fabrication; predictable physicochemical propertiesLimited functionality; no spatial control over nanomaterials, bioactive agents or cell organizationDrug delivery with defined release profiles [87], cell encapsulation for reproducible tissue regeneration [70,88], wound healing [56]Emulsion polymerization [69,89]Precipitation polymerization [55,56]Microfluidics [87,88]Microfluidic electrospray [35,70]Gas shearing [28]Polygon/StarAnisotropic shape with sharp vertices and defined edgesMolding [90]Sharp features transmit shear forces or act as sites of focal mechanical stress to influence cellsPoor injectability due to irregular packing; sharp corners may cause mechanical failure or induce a stronger inflammatory responseCell delivery platforms requiring tissue penetration [90]DLP [91]RodHigh aspect ratio providing directional cuesMolding [27]Provides topographical cues to guide cell alignment and directional migrationCan be difficult to inject without breakingGuided regeneration of aligned tissues [27], vascular engineering [92]Microfluidics [92]HeterogeneousCore-shellA concentric architecture comprising an inner core and an outer shellEmulsion [68]Protects sensitive components (cells, bioactive agenst); enables temporal control of cell behaviorFabrication complexity; risk of premature “burst release” or shell ruptureCell delivery [93], drug delivery [15,68]Microfluidics [94,95]Microfluidic electrospray [15,93]Layer-by-layer assembly [96]HollowAn empty internal cavity surrounded by a solid shellSacrificial template method [97,98]Maximizes loading capacity; provides a large, protected void for cell cultureShell integrity is critical to prevent collapse; can be difficult to load post-fabricationDrug delivery [98], non-invasive cell delivery and culture [24,99]Microfluidics [24,99]JanusTwo distinct hemispheres joined at a single interface, creating anisotropyMicrofluidic electrospray [25,100]Provides dual functionality and directional propertiesInterface stability can be a mechanical weak point; requires precise fluid stream alignmentSequential drug release [25]Gas shearing [28]PPAP [101]MulticompartmentMultiple (>2) physically distinct domains within a single microgelGas shearing [28]Allows simultaneous delivery of multiple, incompatible agents and co-culture of different cell typesHighest fabrication complexity; precise control over compartment size and position is difficultMulti-cellular microtissues [29]PPAP [101] Comparison of architectures of composite microgels. Homogeneous composite microgels Homogeneous microgels contain uniformly distributed components throughout the particle, even if they contain nanoscale heterogeneity caused by dispersed NPs. This uniformity yields predictable and reproducible physicochemical properties, which is essential for applications requiring defined release profiles or consistent mechanical support. However, fabrication within this category involves a fundamental trade-off between precision and scalability. Microfluidic platforms achieve high uniformity by generating droplets of aqueous polymer precursors within an immiscible oil phase, followed by on-chip solidification via controlled crosslinking [87,102,103]. For instance, photopolymerization covalently bonds methacrylate groups in GelMA and/or HAMA networks [49], whereas ionic crosslinking solidifies alginate/collagen (Alg/Col) microgels [21]. The resulting narrow size distributions translate into reproducible mechanical properties across the particle population, which is critical for mechanically sensitive applications such as stem cell mechanobiology where small stiffness differences can shift fate decisions. In contrast, water-in-oil emulsion [20,36] and emulsion polymerization [69,89] accept higher polydispersity in exchange for substantially higher throughput, which can be appropriate when the application is less sensitive to size- and stiffness-dependent variability. Beyond spheres, homogeneous microgels can be fabricated with non-spherical geometries that provide topographical cues not accessible to isotropic particles. Molding enables polygonal architectures (e.g., triangular, quadrilateral, pentagonal, and star-shaped shapes), where sharp vertices and defined edges can transmit shear forces or act as sites of focal mechanical stress to influence cell behavior. For instance, quadrilateral microgels effectively transmit shear forces to surrounding mucus layer under a rotating magnetic field, supporting tissue penetrating cell delivery [90]. Digital light processing (DLP) extends geometric complexity via spatially confined photopolymerization, enabling fabrication of polydopamine (PDA)-coated Fe3O4/GelMA microgels with high structural fidelity for bone tissue engineering [91]. However, DLP remains largely proof-of-concept, as its low throughput and equipment cost currently limit scalability. Rod-shaped microgels provide high-aspect-ratio surfaces that guide cell alignment through contact guidance. This geometry-dependent advantage has been demonstrated using distinct fabrication methods. Particle replication in a non-wetting template (PRINT) produces magnetic rod-shaped microgels via chemical crosslinking in rod-shaped molds, directing fibroblast growth along defined orientations [27]. Microfluidic elongation instead generates droplets in narrow channels followed by covalent photopolymerization, yielding rod-shaped microgels that promote more robust endothelial sprouting in vitro than spheres [92]. Despite their biological advantages, non-spherical architectures introduce practical constraints. Irregular shapes impede dense packing and increase the risk of needle clogging, reducing their suitability for minimally invasive delivery. Non-spherical designs are therefore best justified when the shape-dependent cue is essential to the therapeutic mechanism. Heterogeneous composite microgels Homogeneous microgels provide reproducible microenvironments, but their single compositional domain limits spatial control that encapsulated components experience the same network environment and typically release simultaneously. Heterogeneous microgels overcome this constraint by introducing spatially segregated regions, enabling functions inaccessible to uniform particles. These architectures span increasing complexity, from core-shell and hollow particles to Janus and multicompartment designs. Each added level of compartmentalization expands function but imposes higher fabrication demands. Core-shell microgels provide spatial control over encapsulated substances by separating an inner core from an outer shell. The core offers a defined microenvironment for encapsulated drugs or cells, while the shell functions as a semi-permeable barrier that governs mass transport and allows surface functionality to be tuned independently of the core. Core-shell structures are commonly produced via microfluidics [94,95] or microfluidic electrospray. For instance, microfluidic electrospray produces cell-laden microgels with a CMC core and an alginate shell stabilized by ionic crosslinking with Ca2+ [15]. Alternatively, layer-by-layer (LBL) assembly precisely controls over shell composition and thickness through electrostatic deposition of oppositely charged polyelectrolytes [96]. These methods offer complementary advantages that microfluidics typically provides higher throughput and tighter shell thickness distributions, whereas LBL assembly offers finer compositional control. Importantly, this choice also affects cytocompatibility. Single-step microfluidic encapsulation minimizes processing stress, whereas repeated washing/incubation during LbL assembly may compromise sensitive cell types. A shared limitation is the risk of premature burst release due to shell rupture or heterogeneous crosslinking at the core-shell interface, which can undermine the intended temporal control. Hollow microgels extend the core-shell concept by replacing the solid core with an internal cavity, maximizing loading capacity and providing a protected void for cell culture or high-dose drug loading. Droplet microfluidics generates hollow microgels via outside-in enzymatic oxidative phenolic crosslinking [24,99]. Alternatively, sacrificial templating grafts a shell onto a silica core, followed by core removal [97]. The resulting thin shell architecture enhances responsiveness and diffusion, making hollow microgels attractive for non-invasive drug delivery [98] and cell delivery [24]. However, fabricating requires balancing material versatility with cytocompatibility. While sacrificial templating accommodates diverse shell chemistries, core removal typically precludes cell encapsulation. Moreover, thin shells can be mechanically fragile, risking collapse or uncontrolled release under physiological loads (e.g., in the intra-articular space). Multicompartment microgels represent the highest structural complexity, providing spatial segregation of distinct cell types or incompatible agents to avoid undesirable biological cross-reactions. Advanced manufacturing techniques leverage defined molecular interactions to create such architectures. Gas shearing uses rapid ionic crosslinking of co-laminating alginate streams in a calcium chloride bath to form microgels with up to eight compartments in a single step [28]. Microfluidic electrospray with θ-shaped microchannels produces Janus microgels by exploiting strong electrostatic interactions (e.g., between graphene oxide and chitosan) to stabilize the interface [100], or by joining two hemispheres (HAMA and GelMA) via simultaneous photopolymerization for bone regeneration [25]. Emerging techniques like programmable pulsed aerodynamic printing (PPAP) further expand this space by generating Janus or multi-core droplets that are fixed through on-demand covalent crosslinking [101]. These advanced fabrication methods leverage fundamental material interactions to produce microgels with unprecedented architectural complexity, enabling multi-stage drug release or combined therapies. However, compartment interfaces often remain mechanical weak points. Delamination under shear during injection is therefore a persistent engineering challenge that must be addressed for reliable clinical translation. Ultimately, architectural fidelity, from homogeneous geometries to multicompartment designs, depends on precise control of material interactions during fabrication. Covalent and ionic crosslinking define microgel integrity, while targeted electrostatic forces can stabilize heterogeneous domains. Importantly, these interactions extend beyond individual microgels to guide the assembly of microgels into larger constructs. Surface chemistries such as charges or dynamic bonding can be engineered to control how microgels pack and interact, enabling higher-order structures. The next section therefore discusses how individual microgels are assembled into functional constructs through physical jamming and/or chemical crosslinking. Assembling microgels for functional constructs Composite microgels can function either as dispersed particles or as assembled constructs, representing a final step in translating microscale design into tissue-scale performance. As individual particles, microgels remain free-flowing and injectable, enabling minimally invasive, site-specific drug delivery [60,68] and serving as protective microcarriers for cell cultivation [40,104]. To create larger and mechanically robust structures, however, researchers assemble these discrete building blocks into tissue-scale constructs, including jammed granular hydrogels and 3D bioprinted scaffolds. This bottom-up strategy preserves the modular functionality engineered into each microgel while introducing emergent properties such as interconnected porosity that supports cell infiltration and nutrient transport [17]. The assembly approach governs the mechanical robustness and clinical injectability of the resulting construct, with a central choice between physical jamming and interparticle chemical crosslinking. Physical jamming occurs when microgels are packed above a critical particle-to-volume fraction, typically ∼0.58 (random loose packing) to ∼0.64 (random close packing) [105], such that interparticle contacts and friction produce solid-like behavior without additional bonding. Common jamming methods include centrifuge/filtration [106,107] and flash-solidification [48]. Because stability arises primarily from physical entanglement, jammed microgels typically exhibit pronounced shear-thinning and rapid self-healing, making them well suited for extrusion-based 3D bioprinting [[106], [107], [108]]. However, this also represents a key failure mode that jammed constructs can be susceptible to mechanical degradation under sustained physiological loading. To improve structural integrity, interparticle chemical crosslinking is introduced to stabilize microgel-microgel interfaces and enhance long-term robustness. A key design advantage is that intraparticle crosslink density can be tuned independently from interparticle bonding, enabling constructs that remain injectable yet mechanically stable after placement. For instance, dynamic hydrazone bonding between aldehyde- and hydrazide-functionalized norbornene-modified HA microgels improves mechanical integrity and shape stability while preserving injectability [109]. Similarly, dynamic bonding between PDA-modified HA and phenylboronic acid-functionalized microgels enables bottom-up assembly of cells-laden constructs [103]. However, excessive interparticle crosslinking can reduce matrix dynamics and responsiveness, whereas insufficient bonding compromises mechanical integrity and reproducibility. By balancing static intramicrogel mechanics with dynamic intermicrogel interactions, injectable assemblies protect cells from mechanical stress during delivery while providing a stable engraftment niche [110]. Through rational tuning of these interactions, composite microgels and their assemblies can integrate mechanical support, biochemical signaling, and dynamic responsiveness for therapeutic and regenerative applications. In summary, this section has outlined a function-driven design pathway for composite microgels, from composition and crosslinking to architectures and tissue-scale assembly. These structural choices are not an end in themselves; their significance lies in how they instruct cell behavior and shape tissue outcomes. The next section therefore bridges structure to function by detailing the mechanisms through which engineered microgel properties regulate cell responses. Mechanisms of cell regulation by composite microgels Composite microgels are impactful in biomedical applications because they regulate cell behavior across multiple spatial and temporal scales. While Section 2 outlined design pathways for tuning microgel properties, this section explains how these engineered features translate into cellular responses that ultimately determine therapeutic outcomes. Broadly, cell regulation occurs through two modes: intrinsic material properties which provide stable mechanical, biochemical, and structural cues built into the microgel design, and dynamic regulation, where modulates the cellular microenvironment over time via on-demand stimuli responses or pre-programmed kinetics. Understanding these mechanisms is essential for designing cell-instructive composite microgels that actively guide tissue regeneration rather than merely provide passive support. Cell regulation by intrinsic material properties Intrinsic material properties provide a primary mode of cell regulation by establishing a consistent biophysical and biochemical microenvironment over relevant experimental or therapeutic timescale. These stable cues shape cell adhesion, migration, proliferation, and differentiation. Here, we focus on three interconnected aspects. The mechanical microenvironment provides physical signals that cells sense, the biochemical interface presents molecular instructions for adhesion and signaling, and the structural and spatial control uses the microgel architecture to physically direct cell organization and function. Mechanical microenvironment Mechanotransduction is a fundamental mechanism by which composite microgels regulate cell behavior through mechanical cues. Cells sense their surrounding microenvironment via integrin-mediated adhesions, modulate the formation and activation of focal adhesions (FAs), and convert mechanical forces into biochemical signals by engaging specific molecular signaling pathways such as YAP/TAZ, Rho/ROCK, Wnt/β-catenin, ultimately determining cell fate [111]. Stiffness and viscoelasticity are key mechanical cues that govern cell activities via mechanotransduction [112]. Composite microgels enable mechanical tuning through multiple strategies. The first strategy is to vary crosslinking density by adjusting polymer concentration. For instance, increasing dextran-methacrylate (dextran-MA) concentration yields stiffer fibrin-dextran-MA microgels [113]. Such crosslinking control creates tunable mechanical microenvironments that direct stem cell lineage. As shown in Fig. 2A, BMSCs in low-crosslinked Gel-HA(L) differentiate into hyaline cartilage via TGF-β/Smad and Hippo signaling (Fig. 2A(2)), whereas medium- and high-crosslinked Gel-HA(M/H) activate integrins/YAP/TAZ signaling and drive fibrocartilage formation (Fig. 2A(3)) [80]. Similarly, integrin-binding dextran-tyramine-biotin (Dex-TAB) microgels with elastic modulus of 6.9 ± 1.9 kPa and 70.5 ± 10.8 kPa mimic soft and stiff tissues, respectively, and stiffer microgels promote greater osteogenic calcified matrix formation [116]. Beyond static stiffness, viscoelasticity also matters. In antibody-functionalized alginate microgels, increasing stiffness via stable covalent crosslinks significantly enhances T cell proliferation and upregulates activation markers, whereas ionically crosslinked (more viscoelastic) alginate microgels suppress T cell expansion, suggesting that sustained mechanical resistance is more effective than rapidly relaxing resistance for potentiating activation signals [52].Fig. 2Cell regulation by intrinsic material properties of composite microgels. A. Tunable mechanical microenvironment regulates BMSCs chondrogenesis. (1) Gel-HA microgels with low, medium and high crosslinking densities. (2) Activated and inhibited signal pathways for different BMSCs chondrogenesis in Gel-HA (L) microgels and (3) Gel-HA (M) and Gel-HA (H) microgels. Reproduced with permission [80]. Copyright 2020, Elsevier. B. Composite microgel composition and interfacial chemistry modulates signaling pathways. (1) Illustration of composite microgel with RGD motifs and GFs. (2) Integrin-mediated signaling pathway. Reproduced with permission [114]. Copyright 1999, Science. (3) GFs-induced signaling pathway. Reproduced with permission [115]. Copyright 2021, Springer Nature. C. PEG-TA hollow microgels for non-invasive delivery of immunoprotected β-cells. (1) Fluorescence confocal image displays a hollow microgel. (2) Schematic illustration of the produced microgels to be impermeable to larger size molecules and immune cells while permeable to small molecules like insulin and glucose. (3) Fluorescent confocal images of encapsulated β-cell spheroid immunohistochemically stained for insulin (INS - red) and glucagon (GCG - green). Reproduced with permission [24]. Copyright 2023, Wiley-VCH. (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.) Cell regulation by intrinsic material properties of composite microgels. A. Tunable mechanical microenvironment regulates BMSCs chondrogenesis. (1) Gel-HA microgels with low, medium and high crosslinking densities. (2) Activated and inhibited signal pathways for different BMSCs chondrogenesis in Gel-HA (L) microgels and (3) Gel-HA (M) and Gel-HA (H) microgels. Reproduced with permission [80]. Copyright 2020, Elsevier. B. Composite microgel composition and interfacial chemistry modulates signaling pathways. (1) Illustration of composite microgel with RGD motifs and GFs. (2) Integrin-mediated signaling pathway. Reproduced with permission [114]. Copyright 1999, Science. (3) GFs-induced signaling pathway. Reproduced with permission [115]. Copyright 2021, Springer Nature. C. PEG-TA hollow microgels for non-invasive delivery of immunoprotected β-cells. (1) Fluorescence confocal image displays a hollow microgel. (2) Schematic illustration of the produced microgels to be impermeable to larger size molecules and immune cells while permeable to small molecules like insulin and glucose. (3) Fluorescent confocal images of encapsulated β-cell spheroid immunohistochemically stained for insulin (INS - red) and glucagon (GCG - green). Reproduced with permission [24]. Copyright 2023, Wiley-VCH. (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.) The second strategy uses nanomaterials as rigid fillers to increase stiffness, where higher nanomaterial content and better dispersion typically lead to greater reinforcement. For instance, polylactic acid (PLA) NFs strengthen alginate microgels and increase elastic modulus. In breast cancer models (MCF-7 and SUM-159), softer microgels promote higher cell proliferation and dispersion, whereas stiffer microgels reduce N-cadherin expression, indicating diminished migration and invasion potential [67]. Similarly, fibroblast proliferation increases on Laponite NPs-incorporated microgels, attributed to NPs-induced porous surface topology and tissue-mimetic elasticity, and interactions between NPs and cell-surface receptors [36]. Moreover, localized stiffness from cellulose NFs in PAAs microgels generates strong traction forces that encourage mechanotactic spreading of preosteoblasts (MC3T3-E1), while inhibiting migration by forcing pancreatic cancer cells into compact spheroids [66]. Comparing these approaches highlights that mechanotransduction is not governed by stiffness alone; instead, cell behavior reflects the interplay between elasticity and physical confinement. Increasing stiffness by raising crosslinking density can reduce interstitial space and restrict cell elongation and migration. Thus, although high stiffness can provide osteogenic mechanotransductive cues, concurrent confinement may limit matrix remodeling and tissue connectivity. In contrast, rigid fillers can partially decouple stiffness from porosity, allowing cells to experience an osteogenic mechanical microenvironment while retaining space for migration and proliferation. Importantly, when microgels are assembled into granular scaffolds, the dominant length scale of mechanosensing can shift. In these assemblies, macroscopic porosity and interparticle voids may play a larger role than single-particle stiffness. For example, highly porous granular scaffolds enhance chondrocyte networking and tissue maturation largely independent of individual microgel stiffness [117]. Collectively, effective mechanical regulation requires both localized stiffness to activate mechanosensitive pathways and sufficient physical space for cellular expansion and matrix deposition. Biochemical interface While many single-component microgels (e.g., gelatin-based systems) are intrinsically cell-adhesive, composite microgels broaden the biochemical design space. By integrating multiple components such as RGD motifs and GFs (Fig. 2B(1)), composite designs can introduce bioactivity to otherwise bioinert matrices, enable synergistic signaling, and present multiple biochemical instructions simultaneously. Matrix-bound biochemical cues, particularly immobilized cell-adhesive motifs, are primary drivers for cell-material interactions. Integrins are key receptors mediating cell attachment, spreading, actin organization, and focal adhesion formation [[118], [119], [120]]. The Arg-Gly-Asp (RGD) sequence is the cell attachment site of a variety of ECM and recognized by multiple integrins, constituting a major recognition system for cell adhesion [121]. Natural polymers such as gelatin, collagen, and HA contain RGD sequences that activate focal adhesion kinase (FAK), promoting adhesion and proliferation through integrin-mediated pathways as illustrated in Fig. 2B(2) [114]. However, structurally useful polymers such as alginate lack these motifs. A key advantage of composite design is the ability to overcome this limitation, for example, by conjugating RGD peptides [122], or blending with natural polymers. Alg/Gel microgels support hMSCs adhesion and proliferation [123], and maintain high viability of encapsulated HepG2 cells [124]. Alg/GelMA microgels further provide a supportive 3D microenvironment for co-encapsulated human dental pulp stem cells (hDPSCs) and human umbilical vein endothelial cells (HUVECs), enhancing proliferation, tubular formation, odontogenic differentiation, and ECM secretion [23]. Complementing matrix-bound cues, controlled delivery of diffusible signals such as GFs, regulates cell survival, proliferation, and differentiation. GFs bind to specific cell-surface receptors, trigger autophosphorylation, and activate intracellular signaling cascades. As illustrated in Fig. 2B(3), RAS/MAPK signaling activates multiple transcription factors to regulate cell proliferation and migration, while PI3K/AKT governs cell survival and metabolism through apoptosis-related enzymes [115]. Composite microgels act as micro-reservoirs that protect labile GFs from degradation and release them in a controlled manner, sustaining pathway activation over time. Crucially, composite microgels can synchronize immobilized and diffusible cues to generate synergistic biochemical regulation. For instance, RGD modified alginate microgels provide localized, sustained release of VEGF and hepatocyte growth factor (HGF) to stimulate endothelial cell sprouting, proliferation, migration, and tube formation, while covalently bound RGD promotes cell adhesion and cytoskeletal anchoring required for cells to respond to GF gradients [122]. By coordinating integrin engagement with receptor tyrosine kinase signaling, composite microgels provide a multi-layer biochemical regulatory network that single-component systems often cannot replicate. Beyond immobilized motifs or diffusible GFs, interfacial chemistry of composite microgels profoundly influences cell-material interactions by controlling protein adsorption from biological fluids. The adsorbed protein layer mediates cell adhesion and signaling and is typically tuned through two opposing strategies: promoting bioadhesion or enforcing bioinertness. To promote cell engagement on otherwise inert polymers, functional coatings such as PDA provide a bioinspired adhesive strategy that increases protein adsorption and enables covalent tethering of biomolecules. Inspired by mussel adhesive proteins rich in 3,4-dihydroxy-L-phenylalanine (L-DOPA) [125], PDA with abundant catechol and amine groups strongly adhere to diverse surfaces via hydrogen bonding, π-π stacking, and coordination interactions. PDA increases adsorption of serum proteins such as fibronectin and vitronectin, which contain RGD motifs recognized by integrins. Consequently, PDA-coated alginate microgels show ∼60% higher cell adhesion than uncoated controls [125]. PDA also acts as a spacer for grafting bioactive molecules like VEGF and bone morphogenetic protein 2 (BMP2) to enhance bone regeneration [126], or for conjugating proteins like collagen and fibronectin to promote spheroids formation [127]. Conversely, bioinert layers (e.g., PEG) form antifouling surfaces that resist protein adsorption and prevent unintended cell adhesion. A dense hydration layer formed by hydrophilic, electrically neutral PEG chains reduces protein absorption on copolymer poly-L-lysine-graft-PEG microgels, diminishing cellular uptake and non-specific interactions with macrophages (RAW 264.7), endothelial cells (HUVECs), and epithelial cells (HeLa) [54]. Together, these strategies highlight a core trade-off between amplifying cell-material interaction and enforcing biological inertness. PDA coatings can transform inert microgels into cell-instructive niches by leveraging serum-derived adhesive proteins, but in vivo such non-specific adsorption can introduce variability through uncontrolled biofouling or adsorption of inhibitory proteins that mask intended signals. PEGylation mitigates these risks by suppressing non-specific adsorption but may also limit integrin-mediated adhesion and tissue integration. Thus, interfacial chemistry should be selected based on the intended regulatory mechanism, balancing active adhesion/signaling against the need for immune isolation and bioinertness. Structural and spatial control Composite microgels create distinct microenvironments for encapsulated cells, providing an additional regulatory axis by defining spatial confinement, biophysical shielding, and mass transport. Core-shell microgels regulate cell behavior by providing spatial confinement and biophysical shielding. The core can support cellular functions, such as cellular spheroid formation [15,94] or tissue-specific activity [23,128], while the shell acts as a protective, semi-permeable barrier shielding encapsulated cells from external immune attack [93] and shear stress [128]. Shell mechanics further control spheroid growth: stiffer shells (756 Pa) reduce spheroid size and slow growth, whereas softer shells (45 Pa) yield larger, less regular spheroids [94]. Hollow microgels replace the solid core with an internal cavity, increasing space for cell proliferation and improving nutrient exchange. This architecture is particularly attractive for applications requiring massive cell expansion, such as β-cell transplantation for diabetes treatment. As shown in Fig. 2C, thin-shelled PEG-tyramine (PEG-TA) hollow microgels permit diffusion of oxygen, nutrients, glucose, and insulin, while shielding β-cells from immune cell attacks. Encapsulated β-cells self-assemble into functional spheroids within 24 h, maintaining over 95% viability and expressing insulin and glucagon markers [24]. Multicompartment microgels further expand spatial control by segregating different cell types or materials into distinct compartments. For example, HepG2 and HeLa cells encapsulated in separate compartments maintain high viability and form ordered clusters, recapitulating the complexity of native tissue organization [28]. Overall, compartmentalization sets the physical boundary conditions of the cellular niche, shaping organization, cell-cell communication, and metabolic state. Dense, thick-shell core-shell designs can impose strong confinement and mass-transport limitations, potentially triggering hypoxia-associated signaling or necrotic failure. In contrast, hollow architectures reduce confinement and facilitate spatial reorganization, enabling robust junction formation and spheroid self-assembly. By tuning internal spatial constraints and transport pathways, microgel architectures can shift encapsulated cells from isolated, metabolically constrained states toward proliferative, multicellular networks capable of tissue integration. Dynamic regulation of cellular microenvironment Beyond the stable cues provided by intrinsic material properties, dynamic regulation allows composite microgels to change over time and create microenvironments that adapt to therapeutic needs. Dynamic control involves two distinct mechanisms. On-demand regulation relies on responses to external or environmental triggers (e.g., light, pH, enzymes) that alter microgel properties to regulate cell functions. Autonomous regulation proceeds without external intervention through pre-programmed kinetics, such as controlled degradation rates or cell-paced remodeling. Together, these time-resolved and spatially localized responses better recapitulate the adaptability of living tissues and support precision therapeutics and regenerative medicine. On-demand cell regulation via external stimuli Composite microgels can regulate cell behavior by dynamically responding to external stimuli. Physical stimuli such as temperature and light provide precise external control. Chemical stimuli such as pH or redox conditions exploit disease-site microenvironments, while biological stimuli such as enzymes enable highly specific activation through molecular recognition. Multi-stimuli systems integrate multiple triggers to further increase adaptive and programmable control. Physical stimuli Physical stimuli, including temperature, light, mechanical forces, electric or magnetic fields, provide non-invasive routes for on-demand regulation, typically by inducing reversible changes in microgel structure or function. Transitions between swollen and collapsed states alter network density, pore size, and mechanical microenvironment, thereby regulating cell responses. Temperature-responsive microgels often use thermosensitive polymers such as PNIPAM, which undergoes volume shrinkage above its lower critical solution temperature (LCST, ∼32 °C). For example, Fig. 3A shows a temperature-triggered mechanical squeezing model for tumor spheroids. Shrinkage of a PNIPAM-containing alginate shell at 37 °C consistently transmits pressure to the core, tightening cell-cell junctions, and altering tumor sensitivity to chemotherapeutics [129].Fig. 3On-demand cell regulation via external stimuli. A. Temperature-triggered mechanical squeezing simulates high pressure environment for tumor spheroids. Reproduced under the terms of the CC-BY license [129]. Copyright 2023, The Authors. Published by John Wiley and Sons. B. pH-triggered drug release from PDA-functionalized PVA microgels for inhibited tumor angiogenesis and enhanced tumor cell necrosis. Reproduced with permission [130]. Copyright 2020, American Chemical Society. C. Glucose-triggered selective capturing and killing of cancer cells by dual-functionalized crescent microgels. Reproduced with permission [26]. Copyright 2020, Wiley-VCH. D. Composite dextran microgels combine enzyme- and magnetic-responsiveness to orchestrate a multi-modal treatment for local colon cancer. Reproduced with permission [60]. Copyright 2022, John Wiley and Sons. E. Temperature-, redox-, and pH-responsive microgels for improved targeted drug delivery and cellular apoptosis in the tumor microenvironment. Reproduced with permission [30]. Copyright 2023, Elsevier. On-demand cell regulation via external stimuli. A. Temperature-triggered mechanical squeezing simulates high pressure environment for tumor spheroids. Reproduced under the terms of the CC-BY license [129]. Copyright 2023, The Authors. Published by John Wiley and Sons. B. pH-triggered drug release from PDA-functionalized PVA microgels for inhibited tumor angiogenesis and enhanced tumor cell necrosis. Reproduced with permission [130]. Copyright 2020, American Chemical Society. C. Glucose-triggered selective capturing and killing of cancer cells by dual-functionalized crescent microgels. Reproduced with permission [26]. Copyright 2020, Wiley-VCH. D. Composite dextran microgels combine enzyme- and magnetic-responsiveness to orchestrate a multi-modal treatment for local colon cancer. Reproduced with permission [60]. Copyright 2022, John Wiley and Sons. E. Temperature-, redox-, and pH-responsive microgels for improved targeted drug delivery and cellular apoptosis in the tumor microenvironment. Reproduced with permission [30]. Copyright 2023, Elsevier. Light, particularly near-infrared (NIR) irradiation, offers higher spatial precision and can engage PNIPAM-based networks through two distinct mechanisms with different cellular outcomes. In the first, light acts as a heat source by exciting embedded photothermal agents. For instance, PNIPAM-co-AA microgels chemically linked Prussian blue (PB) respond to NIR irradiation as PB converts light to heat, triggering PNIPAM collapse and enabling thermal ablation [33]. Compared with bulk heating, NIR confines the thermal effect to the irradiated region and reduces collateral damage. In the second mechanism, light induces photocrosslinking rather than photothermal conversion, stiffening the network instead of collapsing it. Using a light-activated initiator system, visible light triggers in situ covalent crosslinking at defined time points, progressively increasing microgel stiffness during stem cell culture and shifting lineage outcomes from osteogenesis towards adipogenesis [116]. These two routes imply a practical design rule. The choice between photothermal agents and photoinitiators should be guided by the required network response (collapse for drug expulsion or compression versus stiffening for differentiation control), while wavelength selection should consider tissue accessibility (NIR for deeper targets; visible light for superficial targets and higher spatial resolution). Although physical stimuli provide precise control over timing and location, clinical translation can be limited by hardware requirements and stimulus constraints, such as limited penetration and difficulty in localizing temperature changes. Selection of a physical trigger should therefore consider both anatomical accessibility and whether the therapeutic mechanism requires network collapse or stiffening. Chemical stimuli In contrast to externally applied physical triggers, chemical stimuli exploit disease-site microenvironments and can enable hardware-free activation. pH, ionic strength, and redox conditions can modulate microgel properties by altering chemical bonding or molecular configuration. Importantly, pH- and redox-responsive systems typically differ in their spatial activation zone, which affects delivery requirements and off-target risks. Fig. 3B illustrates a pH-triggered system engineered for tissue adhesion and controlled release. PDA-functionalized PVA microgels undergo acetal hydrolysis and swell in the mildly acidic tumor microenvironment (pH 6.5), leading to sustained release of bevacizumab (Bev) and docetaxel (DTX). PDA moieties also promote tumor adhesion, increasing retention of Bev at the target site. Therefore, these features enable localized co-delivery with synergistic antitumor effect [130]. By contrast, redox-responsive systems often activate intracellularly. For example, disulfide-containing crosslinkers such as N,N′-bis(acryloyl)cystamine (BAC) can be used to crosslink folic acid (FA)-grafted alginate and PAAm, enabling targeting via folate receptor. In the presence of intracellular glutathione (GSH), disulfide reduction triggers microgel swelling and structural disruption, leading to rapid intracellular drug release and enhanced accumulation while sparing normal cells with lower GSH levels [131]. These strategies highlight a trade-off between accessibility and specificity. pH-responsive microgels are broadly applicable but may activate in inflamed non-tumor tissues, whereas redox-responsive microgels can achieve higher cancer cell specificity via the intracellular GSH gradient but require efficient cellular internalization. Improving both approaches therefore requires engineering surface and structural features to ensure activation occurs in the intended spatial compartment. Biological stimuli Biological cues such as glucose, enzymes, and cell-secreted factors achieve activation through specific biomolecular recognition, allowing microgels to interface directly with local metabolism. By functioning as localized micro-bioreactors, these systems can either generate cytotoxic stress to induce cell death or supply metabolites to support cell survival. Fig. 3C shows glucose-triggered selective capturing and killing of cancer cells using dual-functionalized crescent microgels. The inner cavity is functionalized with epithelial marker epithelial cell adhesion molecule (EpCAM) antibodies to selectively capture lung cancer cells. Simultaneously, glucose oxidase (GOX) in the gel matrix catalyzes glucose oxidation, generating locally high H2O2 concentrations within the cavity and killing ∼90% of trapped cancer cells while sparing surrounding healthy cells [26]. In regenerative settings, alginate microgels can act as bioreactors that provide sustained glucose to transplanted MSCs under ischemic conditions. By embedding starch and amyloglucosidase, the microgel autonomously converts starch into glucose via enzymatic hydrolysis. This sustained release of glucose creates a pro-survival and pro-regenerative microenvironment, improving MSC survival and promoting angiogenesis in vivo [132]. Together, these examples illustrate two opposing modes of metabolic regulation: localized oxidative stress versus metabolic rescue. Systems that rely on ambient metabolites can convert benign substrates into cytotoxic stressors to drive apoptosis, whereas self-contained bioreactors generate essential nutrients to support survival and shape a pro-regenerative, immunomodulatory phenotype. Both face translational constraints. Oxidative systems depend on sufficient ambient glucose to reach cytotoxic thresholds, whereas bioreactor systems are limited by finite substrate reservoirs. Clinical translation therefore requires robust metabolic control despite patient-to-patient variability and systemic fluctuations. Multi-stimuli systems By integrating multiple sensing and responding mechanisms within a single network, composite microgels can function as programmable therapeutic actuators. Multi-stimuli designs can enhance therapeutic specificity through sequential activation, amplify cell responses via synergistic triggering, or impose conditional activation to restrict regulation to specific cell populations. However, each additional responsive element increases synthesis complexity and introduces additional failure modes in heterogeneous in vivo environments. Sequential activation is most useful when regulation requires temporally separated biological events, such as site-specific release followed by externally triggered cytotoxicity. For instance, composite dextran microgels (Fig. 3D) combine enzymatic and magnetic triggers for colon cancer therapy. The microgel's dextran matrix is first degraded by colonic dextranase, ensuring site-specific release of cisplatin/SPION lipid NPs. This microgel-mediated delivery enhances intracellular accumulation. Then, an external magnetic field induces localized hyperthermia from internalized SPIONs, disrupting intracellular homeostasis and synergizing with cisplatin to induce cell death [60]. In a different sequential strategy, dual-responsive HA-functionalized PNIPAM microgel films use two physical triggers in sequence to dynamically regulate cell-material interactions. HA promotes CD44-dependent adhesion of breast cancer cells, cooling below the PNIPAM LCST partially weakens adhesion through swelling, and UV irradiation completes cell detachment by chemically cleaving HA-CD44 binding [55]. These systems reveal a key trade-off. Biological first-stage triggers can support autonomous cellular uptake and site specificity, whereas physical first-stage triggers offer precise temporal control but require accurate stimulus delivery. Synergistic responsiveness applies multiple triggers simultaneously to amplify cell responses. For instance, incorporating PAAc into PNIPAM microgel creates dual pH- and temperature-responsiveness. At neutral pH, electrostatic repulsion among deprotonated PAAc chains loosens the network, while at physiological temperature PNIPAM collapse compresses the network, together accelerating drug delivery [29]. Adding AuNRs further amplifies this response by introducing photothermal conversion, strengthening apoptotic effects through combined heating and accelerated release [133]. However, increasing stimulus complexity also increases the risk of unintended coupling between responsive elements. Conditional activation represents the most stringent multi-stimuli design. For example, PNIPAM/PAA/BAC microgels (Fig. 3E) respond to temperature, redox, and pH, remaining stable and non-toxic under normal physiological conditions but undergoing significant structural changes only upon endocytosis into tumor-like intracellular environments (low pH, elevated GSH levels, and increased temperature). The site specific and near-total drug release maximizes tumor killing while limiting off-target toxicity [30]. External controllability can be added by replacing one trigger with an externally applied magnetic field. Temperature- and redox-responsive microgels incorporating magnetic NPs can undergo intracellular disassembly accelerated by magnetothermal heating, promoting nuclear drug accumulation and selective cytotoxicity in MCF-7 cells [134]. Similarly, water-soluble cystine derivative N,N′-diacryloyl-L-cystine disodium salt (DACS) crosslinkers can preserve intracellular gating while improving drug loading up to 98% through electrostatic interactions, achieving accelerated apoptotic regulation under mild redox conditions [135]. While sequential and synergistic schemes improve timing and magnitude of regulation, conditional activation introduces a major clinical limitation that therapeutic success depends on the uniform presence of all required pathological markers. In heterogeneous tumors, subpopulations lacking one marker may escape regulation. Successful translation therefore requires balancing sophisticated regulatory logic with biological variability and manufacturing practicality. Autonomous cell regulation via pre-programmed kinetics While on-demand regulation depends on external triggers for activation, autonomous regulation executes pre-determined actions without external intervention. In these systems, engineered release kinetics, degradation profiles, or cell-paced dynamics autonomously guide tissue development and regeneration, better reflecting time-dependent progression of many biological processes. A common strategy is to program release kinetics directly into microgel composition and structure to achieve spatiotemporal control over cell behaviors. For example, Janus microgels in Fig. 4A comprise HAMA and GelMA hemispheres. By tuning polymer concentration and crosslinking density, the HAMA domain enables an early release of VEGF to initiate angiogenesis, followed by sustained release of BMP2 from the denser GelMA domain to support long-term osteogenesis. This staged delivery, encoded in the microgel structure, improves therapeutic outcomes by recapitulating natural bone healing mechanisms [25].Fig. 4Autonomous cell regulation via pre-programmed kinetics. A. Spatiotemporal release of VEGF and BMP2 from Janus microgels for sequential angiogenesis and osteogenesis in bone regeneration. Reproduced with permission [25]. Copyright 2023, Elsevier. B. 3D bioprinting of living tissue constructs with layer-specific GFs-loaded microgels for zonal tenogenesis, chondrogenesis, and osteogenesis at the tendon-to-bone interface. Reproduced with permission [136]. Copyright 2022, Elsevier. C. Temporally colon-targeted drug delivery from bilayer microgels for the treatment of ulcerative colitis. Reproduced with permission [68]. Copyright 2023, Elsevier. D. Self-regulated and feedback-controlled co-transplantation of islets-laden microgels and biodegradable oxygen-generating microspheres for diabetes treatment. Reproduced with permission [137]. Copyright 2022, American Chemical Society. Autonomous cell regulation via pre-programmed kinetics. A. Spatiotemporal release of VEGF and BMP2 from Janus microgels for sequential angiogenesis and osteogenesis in bone regeneration. Reproduced with permission [25]. Copyright 2023, Elsevier. B. 3D bioprinting of living tissue constructs with layer-specific GFs-loaded microgels for zonal tenogenesis, chondrogenesis, and osteogenesis at the tendon-to-bone interface. Reproduced with permission [136]. Copyright 2022, Elsevier. C. Temporally colon-targeted drug delivery from bilayer microgels for the treatment of ulcerative colitis. Reproduced with permission [68]. Copyright 2023, Elsevier. D. Self-regulated and feedback-controlled co-transplantation of islets-laden microgels and biodegradable oxygen-generating microspheres for diabetes treatment. Reproduced with permission [137]. Copyright 2022, American Chemical Society. This design logic can be extended from single particles to tissue-scale constructs. As shown in Fig. 4B, 3D bioprinting organizes distinct GFs-loaded microgels into layered assemblies for zonal differentiation of embedded stem cells. Layer-specific release kinetics provide sustained, localized signaling that guides tenogenic, chondrogenic, and osteogenic differentiation. In vivo, these patterned assemblies enhance enthesis regeneration by promoting collagen deposition and alignment and reconstructing fibrocartilage features at the tendon-to-bone interface [136]. Autonomous regulation can also be engineered through sequential degradation in response to anatomical transit and site-specific biological cues. Fig. 4C illustrates orally delivered bilayer microgels for temporally staged ulcerative colitis therapy. In the stomach (pH 1.2), the pH-responsive Alg/CS outer layer protects curcumin from premature release. As the system transits the small intestine, the outer layer gradually swells and degrades, causing slow drug release. Upon reaching the colon, the inner core (guar gum/low methoxyl pectin) undergoes colonic enzyme-mediated degradation, concentrating release in inflamed colonic tissue. This layered, pre-programmed degradation sequence sustains drug accumulation in the colon up to 24 h post-administration and improves therapeutic efficacy [68]. Beyond unidirectional, pre-programmed release sequences, the most advanced autonomous systems establish closed-loop feedback control by sensing local biological signals and adjusting responses accordingly. These systems can detect cues such as glucose, pH, oxygen, or metabolites, and self-regulate to maintain homeostasis. As illustrated in Fig. 4D, a co-transplantation platform combining islet-laden composite microgels with biodegradable oxygen-generating microspheres provides staged regulation across distinct temporal stages. Immediately after transplantation, the composite microgels provide physical immunoprotection while in situ oxygen release mitigates acute hypoxia and stabilizes islet metabolism. Concurrently, the microgel network supports sustained release of anti-inflammatory and immunosuppressive agents. Once the microenvironment stabilizes, the composite microgel continues to function as a semi-permeable, immunoisolating barrier that permits glucose-responsive insulin secretion, long-term glycemic regulation via a closed-loop feedback circuit [137]. Taken together, staged release, sequential degradation, and closed-loop feedback represent three distinct routes to autonomous regulation without external triggers. These strategies also highlight a trade-off between autonomy and adaptability. Pre-programmed systems are simpler but cannot respond to unexpected physiological changes, whereas feedback-controlled systems can adapt in real time but depend on sustained viability and function of encapsulated cells. Successful clinical translation therefore requires matching the material's functional lifespan and regulatory logic to the biological timeline of the target tissue and therapeutic goal. Biomedical applications of multifunctional composite microgels Multifunctional composite microgels have emerged as powerful platforms across biomedical applications due to their modular composition and structure, stimuli-responsive behavior, and ability to regulate cellular microenvironments. Their tunable physicochemical features enable targeted cancer therapy, enhanced tissue regeneration, accelerated wound healing, and advanced diagnostic or sensing functions. While we organize our discussion by these distinct application areas in this section, it is important to note that many of the underlying functional principles, such as controlled drug delivery, cell encapsulation, and immunomodulation, are shared across these fields. Together, these capabilities position composite microgels as versatile systems that seamlessly bridge fundamental design principles with translational clinical needs. Cancer therapy Composite microgels offer a highly tailorable platform for cancer therapy by enabling precise control over drug delivery, physical ablation, catalytic activity, and immune modulation. Their structural design and stimuli-responsive behavior support selective tumor targeting, enhanced intratumoral retention, and programmable therapeutic activation within the tumor microenvironment. These capabilities make composite microgels as powerful tools for advancing both conventional and emerging cancer treatment modalities, from diagnosis to multimodal therapy. Cancer diagnosis and imaging During early tumor progression, cancer cells can enter the bloodstream, circulate, and disseminate, causing metastasis or recurrence. Early diagnosis is therefore crucial for malignancy assessment and therapy selection. EpCAM antibody is commonly used as a marker for selective detection of circulating tumor cells (CTCs) [138]. Composite microgels are increasingly explored for early diagnosis, particularly through the selective capture and monitoring of CTCs (Fig. 5A). In this example, PNIPAM-AA microgels loaded with EpCAM antibody conjugated Fe3O4 NPs capture MCF-7 cells with up to 87% efficiency in a bilayer magneto-microfluidic platform. Following capturing, the nano/hybrid microgels enable real-time monitoring by staining cells with released dyes upon increasing temperature. This strategy integrates magnetic separation, antibody-based recognition, and stimuli-triggered staining within a single microgel platform, enabling early-stage diagnosis and real-time monitoring of cancer biomarkers [139].Fig. 5The applications of composite microgels for cancer therapy. A. Microfluidic-assisted CTC isolation and in situ capturing, monitoring, and staining of cancer cells by nano/hybrid microgels. Reproduced under the terms of the CC-BY license [139]. Copyright 2023, The Authors. Published by John Wiley and Sons. B. Bioinspired microgels for sustained hyperthermia and chemodynamic effects. Reproduced with permission. Copyright 2026, John Wiley and Sons. C. Poly-HEMA/CS core-shell microgels for combined chemotherapy and PDT. Reproduced with permission [140]. Copyright 2019, Elsevier. D. Cryo-shocked cancer cell microgels for immunotherapy and tissue regeneration. Reproduced under the terms of the CC-BY license [70]. Copyright 2023, The Authors. Published by Elsevier. The applications of composite microgels for cancer therapy. A. Microfluidic-assisted CTC isolation and in situ capturing, monitoring, and staining of cancer cells by nano/hybrid microgels. Reproduced under the terms of the CC-BY license [139]. Copyright 2023, The Authors. Published by John Wiley and Sons. B. Bioinspired microgels for sustained hyperthermia and chemodynamic effects. Reproduced with permission. Copyright 2026, John Wiley and Sons. C. Poly-HEMA/CS core-shell microgels for combined chemotherapy and PDT. Reproduced with permission [140]. Copyright 2019, Elsevier. D. Cryo-shocked cancer cell microgels for immunotherapy and tissue regeneration. Reproduced under the terms of the CC-BY license [70]. Copyright 2023, The Authors. Published by Elsevier. While CTC capture provides powerful ex vivo liquid biopsy workflows, in vivo tumor localization requires different strategies. Here, composite microgels can act as “smart” contrast agents that activate in response to the tumor microenvironment. For instance, temperature- and pH-responsive microgels incorporating fluorescent dyes (R6G, MB, Cy) and ultrasmall AuNPs support photoacoustic imaging and photothermal therapy (PTT). Under mildly acidic conditions (pH ∼5.5), microgel shrinkage promotes AuNPs aggregation, inducing plasmon coupling that enhances photoacoustic signal. Meanwhile, broadened and red-shifted optical absorption toward the NIR improves PTT under irradiation [57]. Importantly, these two diagnostic modalities face distinct translational barriers. Ex vivo CTC platforms generally face fewer regulatory hurdles and offer immediate utility for liquid biopsies, whereas successful in vivo contrast agents must achieve high signal-to-noise ratios while ensuring complete and safe clearance of inorganic NPs after imaging. Physical and catalytic cancer therapy In physical and catalytic cancer therapies, composite microgels function as active therapeutic systems that can provide drug-free treatment modalities. By incorporating photothermal agents [57] or magnetic NPs [61], these platforms convert external stimuli or tumor-associated biochemical cues into localized cytotoxic effects, including tumor ablation or ROS generation. A primary strategy is to use composite microgels as carriers for PTT, delivering photothermal agents such as AuNPs to generate localized heat within tumors. For example, incorporating ultrasmall AuNPs (<4 nm) into stimuli-responsive networks (e.g., PNIPAM-AA microgels) enables responsiveness to tumor-relevant pH and temperature. This dual responsiveness enhances therapeutic outcomes, as acidic environments exacerbate tumor cell death during NIR-induced heating [57]. Another strategy uses bioinspired microgels to address translational limitations such as poor nanoparticle retention. As illustrated in Fig. 5B, sunflower pollen microgels with spiky exine morphology enable “geometry-guided retention” through mechanical interlocking in tumor tissue, prolonging Fe3O4 NPs retention compared with free NPs. This enhanced residence supports repeated activation by an alternating magnetic field, providing sustained hyperthermia and chemodynamic effects. Importantly, the pollen matrix undergoes tumor microenvironment–responsive degradation under oxidative and acidic conditions, supporting post-treatment clearance. Together, morphology-driven retention and tumor-responsive degradation enhance tumor accumulation and extend efficacy in magnetic hyperthermia [61]. Despite these advances, purely physical and catalytic approaches may struggle to eradicate tumor margins because heat or ROS distribution can be heterogeneous in dense tumor tissue. Accordingly, drug-free microgels are increasingly positioned as neoadjuvant strategies that cytoreduce tumors and disrupt stromal barriers, thereby sensitizing residual disease to subsequent pharmacological or immunological interventions. Chemotherapy-integrated cancer therapy Composite microgels also enable chemotherapy-integrated cancer therapy by coordinating anticancer drug delivery with additional modalities to achieve synergistic cytotoxicity. Prominent strategies include combining chemotherapy with PTT (triggered hyperthermia plus accelerated drug release) or with photodynamic therapy (PDT), where irradiation generates cytotoxic ROS. Magnetothermal approaches provide another route for deeper tissue targets. In PTT-chemotherapy systems, photothermal agents such as AuNPs [69], PB [33], or gallium-based liquid metal NPs [141] convert NIR light into localized heat. This can directly induce hyperthermic cell death while simultaneously triggering shrinkage of thermoresponsive matrices (e.g., PNIPAM), accelerating release of co-loaded chemotherapeutics such as DOX [33]. Some systems further enhance targeting through folate receptor conjugation or improve biosafety using core-shell architectures [141]. A key advantage of PTT-chemo synergy is high spatiotemporal control because therapy is confined to the irradiated region; however, limited NIR penetration can restrict efficacy in deep tumors. Alternatively, chemotherapy can be combined with PDT. As illustrated in Fig. 5C, a core-shell microgel containing the photosensitizer pheophorbide A (PheoA) in the core and a ROS-responsive drug-conjugated chitosan shell uses a single NIR trigger to initiate a two-stage effect. ROS generation induces immediate photodynamic damage and then cleaves shell linkers to release the chemotherapeutics locally [140]. However, efficacy depends on light delivery and adequate oxygen levels, which can be limiting in hypoxic tumors. Magnetothermal therapy offers deeper tissue penetration than light-based approaches. For example, dextran microgels delivering cisplatin/SPION lipid NPs can target folate receptor–expressing colon cancer cells. Alternating magnetic fields generate localized heat from SPIONs, synergizing with cisplatin to suppress tumor growth [60]. While magnetothermal systems can access deeper targets, they require specialized equipment and careful control to avoid off-target heating. Across these modalities, the defining advantage of composite microgels is spatiotemporal synchronization. By co-localizing physical disruption of the tumor matrix with chemotherapeutic release, microgels can reduce failures associated with poorly coordinated systemic combination dosing. Clinically, however, this potency must be balanced against risks such as premature microgel degradation during circulation and resulting systemic toxicity. Immunotherapy In cancer immunotherapy, composite microgels serve as immunomodulatory platforms capable of delivering antigens, adjuvants, cytokines, or immune checkpoint inhibitors with spatial and temporal precision. Their tunable microenvironments can support antigen presentation, recruit immune cells, and regulate activation of innate and adaptive responses. By coupling materials engineering with immunological pathways, composite microgels enable localized cancer vaccination, enhanced T cell responses, and multimodal combinations. One major strategy uses composite microgels as in situ cancer vaccines that deliver immunoadjuvants to trigger local antitumor immunity. For example, cryo-shocked cancer cell microgels (Fig. 5D) encapsulate an immunoadjuvant (cytosineguanosine oligonucleotide, CpG ODN) to recruit and activate dendritic cells, incorporate an immune checkpoint inhibitor (antiprogrammed death receptor 1, anti-PD-1) to simultaneously initiate immunity and block tumor immune evasion while supporting tissue regeneration [70]. Alternatively, synthetic microgels deliver potent immunomodulators such as the STING adjuvant diABZI together with LTX-315, activating the STING pathway and strengthening antitumor responses [142]. Together, these strategies leverage tumor-derived antigens to promote localized and potentially personalized immunity. Beyond vaccination, other approaches aim to continuously modulate the tumor immune microenvironment by controlling local concentrations of immune-signaling molecules. For instance, microgels encapsulating genetically engineered bacteria can locally produce CCL21 to recruit immune cells and suppress tumor growth [143]. Oncolytic microgels can provide sustained release of checkpoint antibodies (e.g., anti-PD-1, anti-PD-L1, anti-CTLA-4) while oncolytic peptides induce immunogenic cell death, enabling durable local immunomodulation with reduced systemic exposure [71]. A third strategy involves delivering living therapeutic agents, including probiotics or immune cells. Orally administered CS/Alg microgels carrying Escherichia coli Nissle 1917 (EcN) can modulate gut microbiota and induce tumor apoptosis; in combination with Galunisertib (a TGF-β inhibitor), they can further promote CD8+ T cell infiltration and activation [144]. In a more direct approach, encapsulating natural killer (NK) cells in microgels can enhance proliferation and tumor-killing activity, followed by microgel degradation to release functional NK cells at the target site [145]. Despite strong therapeutic promise, living-material systems face significant translational challenges, including manufacturing consistency, storage stability, and regulatory complexity. By physically anchoring immunomodulators within the tumor bed, composite microgels can decouple potent local immune activation from severe systemic toxicity. Future designs may further benefit from combining immune delivery with remodeling of the tumor stroma (e.g., stiffness and hypoxia), which can otherwise drive immune exhaustion. Overall, composite microgels represent a shift from passive delivery vehicles to active, multifunctional therapeutic platforms. Across diagnosis, physical therapy, chemotherapy integration, and immunotherapy, their shared advantage is spatiotemporal control over the tumor microenvironment through integrated spatial, temporal, and molecular targeting. However, increasing platform complexity also raises manufacturing costs, regulatory burden, and failure modes in heterogeneous clinical settings. Successful translation will therefore require identifying an optimal level of complexity that is sufficient to overcome tumor barriers yet robust enough for scalable manufacturing and consistent performance across patients. Tissue engineering and regenerative medicine Composite microgels have emerged as promising platforms for tissue engineering and regenerative medicine, spanning applications from mechanically robust musculoskeletal repair to metabolically active cellular constructs. This section summarizes representative uses in bone and cartilage regeneration, wound healing, and pancreatic tissue engineering for diabetes management, highlighting how material composition and architecture are matched to application-specific biological requirements. Bone tissue engineering A primary strategy in bone regeneration uses composite microgels to mimic native bone matrix, which is primarily composed of collagen and hydroxyapatite (HAp) [62,146]. These biomimetic scaffolds provide an osteoconductive framework that supports cell adhesion and proliferation, but clinical efficacy can be limited by insufficient osteoinductive signaling. For example, HAp/Col/CS microgels implanted into a 4 mm full-thickness critical-sized calvarial defect in mouse model bridge the bone cavities only when loaded with osteogenically pre-differentiated MSCs. When loaded with undifferentiated MSCs, mineralized tissue forms only adjacent to native bone [62]. This reveals a key translational limitation. Purely osteoconductive microgels make bone regeneration highly dependent on cell pre-commitment, complicating manufacturing and regulatory pathways for cell therapies. To increase intrinsic bioactivity, substituting stable HAp with non-stoichiometric precursors like vaterite in PEG-based microgels provides a more reactive calcium source, supporting bone mineralization and shifting the microgel from a passive scaffold to an active participant in matrix deposition [34]. A second strategy actively promotes osteogenesis and angiogenesis by engineering biophysical and biochemical microenvironment within microgels. Biophysical induction can be achieved by tuning network composition, for example by combining GelMA, HANA, and HAMA to create osteo-supportive niches for hMSCs differentiation [147], or by incorporating PDA-decorated Fe3O4 NPs to generate magnetic microenvironment that upregulates osteogenic gene expression [91]. More commonly, microgels serve as reservoirs for osteogenic and angiogenic signals, ranging from small molecules such as quercetin absorbed on HAp NPs [146] to complex biological payloads such as decalcified bone matrix (DBM) and VEGF [83]. To mimic natural, multi-phasic process of bone healing, architectural innovations like Janus microgels offer sequential delivery of VEGF and BMP2, coordinating early angiogenesis and subsequent osteogenesis [25]. Alternatively, composite microgels deliver chemically modified RNA (cmRNA), such as BMP7 cmRNA, to transfect hMSCs and promote strong osteogenic differentiation without recombinant proteins [148]. These delivery platforms can also be adapted for pathological bone defects. Incorporating antimicrobial peptide (AMP) and cerium dioxide (CeO2) microspheres provides synergistic antibacterial and antioxidant functions in infected alveolar bone defects [51], while Ce/selenium co-doped mesoporous bioactive glass (BG) suppress residual tumor cell activity while supporting bone formation [63]. Across these approaches, a critical clinical requirement is achieving an optimal therapeutic window. The localized signal must be strong enough to drive regeneration while remaining controlled to avoid off-target effects such as ectopic ossification or excessive inflammation. While injectable microgels are effective for filling irregular defects, regeneration of large, load-bearing bone segments often requires macroscopic assembly. 3D bioprinting can organize microgels into tissue-scale constructs with defined architectures, where microgels act as both structural building blocks and protective niches. For instance, Col I/Alg core-shell microgels shield encapsulated cells from destructive shear stresses during printing while contributing to scaffold architecture [128]. Beyond structural control, bioprinted microgel assemblies coordinate metabolic interventions. As shown in Fig. 6A, a 3D printed microgel/hydrogel scaffold co-delivers Mg2+ and BMP2 to manipulate cellular bioenergetics. Mg2+ increases cellular metabolic levels and thereby enhances BMP2 osteoinductivity, promoting robust bone regeneration in a rat cranial defect model even at low BMP2 doses [149]. Pushing the boundaries of structural engineering, “living” biocomposites can be fabricated by printing bacteria-loaded gelatin microgels, which harnesses bacterial urea hydrolysis to induce calcium carbonate precipitation, converting a soft scaffold into a hard, bone-like biomineral composite [150]. Ultimately, translation will require balancing biological orchestration with the mechanical demands of the load-bearing skeletal environment.Fig. 6The applications of composite microgels for tissue engineering and regenerative medicine. A. 3D bioprinted microgel/hydrogel composite scaffold for the orchestration of energy metabolism and osteogenesis. Reproduced under the terms of the CC-BY license [149]. Copyright 2022, The Authors. Published by Elsevier. B. A degradable heterogeneous microgel assembly (F/S-MA) promotes articular cartilage regeneration and repair. Reproduced with permission [157]. Copyright 2024, Royal Society of Chemistry. C. Hierarchically porous injectable microgels (PHIGels) with interior spiral canals deliver MSCs for chronic wound healing. Reproduced with permission [167]. Copyright 2024, John Wiley and Sons. D. Bioartificial pancreas constructed by microencapsulating islets in core-shell microgels and macroencapsulating within a prevascularized hydrogel scaffold for type 1 diabetes treatment. Reproduced under the terms of the CC-BY license [43]. Copyright 2023, The Authors. Published by Elsevier. The applications of composite microgels for tissue engineering and regenerative medicine. A. 3D bioprinted microgel/hydrogel composite scaffold for the orchestration of energy metabolism and osteogenesis. Reproduced under the terms of the CC-BY license [149]. Copyright 2022, The Authors. Published by Elsevier. B. A degradable heterogeneous microgel assembly (F/S-MA) promotes articular cartilage regeneration and repair. Reproduced with permission [157]. Copyright 2024, Royal Society of Chemistry. C. Hierarchically porous injectable microgels (PHIGels) with interior spiral canals deliver MSCs for chronic wound healing. Reproduced with permission [167]. Copyright 2024, John Wiley and Sons. D. Bioartificial pancreas constructed by microencapsulating islets in core-shell microgels and macroencapsulating within a prevascularized hydrogel scaffold for type 1 diabetes treatment. Reproduced under the terms of the CC-BY license [43]. Copyright 2023, The Authors. Published by Elsevier. Cartilage tissue engineering In cartilage repair, particularly osteoarthritis (OA), composite microgels must operate in mechanically demanding, high-shear joints with rapid clearance. Early strategies focus on symptomatic relief and joint preservation by engineering microgel surfaces to address retention and lubrication. For example, 4-arm PEG-maleimide microgels loaded with PLGA NPs and cartilage- or synoviocyte-binding peptides prolong intra-articular retention [151]. Other designs prioritize lubrication rather than adhesion that core-shell metal-organic frameworks (MOFs) NPs/PNIPAM microgels provide low-friction lubrication with thermoresponsive release [152], while HAMA microgels functionalized with 2-methylacryloyloxyethyl phosphorylcholine reduce friction at the joint interface [35]. Composite microgels also deliver anti-inflammatory or pro-chondrogenic agents locally. Curcumin-loaded PEG/GelMA microgels suppress inflammation and promote cartilage regeneration in post-traumatic OA models [153], while kartogenin-loaded cyclodextrin NPs in BMSCs-laden GelMA/HAMA-PBA microgels maintain cell viability and support chondrogenesis in rabbit femoral defects [103]. These joint-preservation strategies illustrate a key trade-off that highly lubricious, antifouling surfaces can reduce mechanical wear but may also limit tissue integration needed for long-term local delivery. Thus, selecting adhesive, lubricious, or drug-focused designs should be guided by OA stage and dominant failure mechanism. A more pro-regenerative strategy aims to rebuild cartilage by delivering and supporting MSCs. Direct approaches use microgels as biochemical and structural templates to guide cell fate. RGD-modified SilMA/DNA microgels can form cartilage organoid precursors and enhance regeneration in rat models [154], while injectable Gel/HA microgels encapsulating BMSCs can self-assemble into cartilage-like scaffolds for chondral defect repair [155]. Chemical coupling further assembles hBMSCs-laden microgels into cohesive 3D constructs that support robust chondrogenesis [88]. Indirect strategies instead remodel the host microenvironment. For example, RGD/HAMA microgels delivering macrophage membrane-camouflaged selenium NPs scavenge ROS and suppress M1 polarization, protecting chondrocytes from oxidative stress and ECM degradation [156]. More advanced systems integrate these concepts with dynamic spatiotemporal control. As illustrated in Fig. 6B, degradable heterogeneous microgel assemblies (F/S-MA) orchestrate multi-step regeneration by using fast-degrading microgels to release chemokines and recruit endogenous MSCs into interconnected “micro-nest” spaces, followed by slow-degrading microgels that promote cell condensation and matrix deposition [157]. Clinically, the key challenge remains ensuring durable hyaline cartilage formation rather than fibrocartilage. Future designs must therefore balance immediate mechanical demands with sustained biochemical signaling that stabilizes mature chondrocyte phenotypes. Wound healing and skin regeneration Composite microgels are being developed into multifunctional wound dressings that address diverse wound types, from acute hemorrhage to chronic non-healing ulcers. For irregular, non-compressible bleeding wounds, rapid hemostasis is the primary goal. Microgel powders are well suited because they rapidly absorb fluids, concentrate clotting factors, and conform to complex geometries. Two broad approaches dominate: in situ chemical assembly and physical/biomimetic blockage. Chemical self-assembly relies on rapid interactions upon contact with blood. For example, microgel assembly powders (MAP) use long-chain alkyl quaternized chitosan (LQCS) to crosslink erythrocytes with oxidized dextran/GelMA microgels [158], while water-triggered cationic microgels with PAAc form self-fusing adhesives for sutureless sealing [159]. Universal crosslinkers such as tannic acid-grafted carboxymethyl chitosan (CCTA) can further accelerate gelation across polysaccharide powders [160]. In contrast, physical and biomimetic strategies provide immediate mechanical plugging. Composite microgels incorporating platelet-like particles (PLPs) with AuNPs or AgNPs and PNIPAM mimic platelet-driven clot retraction [56,161], while positively charged, densely crosslinked microgels provide immediate blockage and then reinforce the barrier via interactions with red blood cells and fibrin [162]. These approaches highlight a practical trade-off. Chemical assembly improves adhesion and sealing strength but requires optimized kinetics under high-flow bleeding, whereas physical blockage is rapid but may provide less support for later healing phases. For incisional wounds, the major challenge shifts to preventing fibrosis and promoting regenerative healing. Composite microgels can modulate the wound environment, either biochemically or biophysically. Biochemical approaches include GelMA/HAMA microgels encapsulating interleukin-10 (IL-10)-loaded Laponite NPs to modulate macrophage activation and suppress fibroblast-driven scarring [36]. Biophysical strategies can address hypoxia and mechanical stress directly. For example, rod-shaped, oxygen-generating composite microgels assemble breathable, porous wound dressings that simultaneously improve local oxygenation and provide directional cues, enhancing skin regeneration while alleviating hypertrophic scar formation [163]. From a translational perspective, biophysical remodeling offers a distinct advantage. From a translational perspective, biophysical strategies may offer improved shelf-life and simpler regulatory paths than cytokine-based systems. For infected wounds, dressings must integrate antimicrobial and antioxidant functions to reduce bacterial burden and oxidative damage. Homogeneous multifunctional injectables include microgels loaded with baicalein@tannic acid NPs for antibacterial and antioxidant activity [164], dual-responsive PNIPAM-co-AA microgels that enable controlled release and mechanical compliance [29], and PDA-functionalized gelatin microgels that provide adhesion, ROS scavenging, and inflammation modulation without added drugs [165]. However, homogeneous systems expose the entire wound to all agents simultaneously. Spatially segregated constructs can be achieved via 3D printing; for example, dynamic bioinks composed of HAMA-PBA/GelMA microgels can be printed into bilayer dressings with chlorhexidine diacetate in the upper layer to suppress surface inflammation and BG in the lower layer to promote infiltration and healing [102]. However, assembling these injectable microgels into a pre-defined 3D structure sacrifices in situ conformability, limiting the application of bilayer dressings to accessible, open wounds rather than deep, tunneling injuries. Chronic diabetic wounds present the greatest complexity due to persistent inflammation, poor angiogenesis, and recurrent infection. Strategies range from passive architectural support to active biochemical, biomechanical, or even living therapeutic components. Architecturally, injectable microporous granular microgel-fiber hydrogels create interconnected porous networks that support cell migration and angiogenesis [166]. More advanced designs include hierarchically porous injectable microgels (PHIGels) within interior spiral canals (Fig. 6C) that significantly improve MSCs survival, retention, and infiltration at the wound site, reducing inflammation and enhancing angiogenesis, collagen deposition, and re-epithelialization in diabetic rat models [167]. Moving beyond passive architecture, multi-stimuli-responsive systems dynamically regulate the wound microenvironment. Thermal-responsive hydrogels incorporating poly(ethylene glycol) methacrylate (PMO)/CMC microgels provide two-stage, temperature-controlled drug release with enhanced mechanical strength and self-healing capability [168]. More autonomously, pH/ROS-responsive microgel systems sequentially release TP, Zn2+, and deferoxamine to simultaneously suppress oxidative stress, reduce inflammation, and promote angiogenesis [169]. This autonomous targeting can be combined with external control. For example, pH/NIR-responsive microgels loaded with Sanghuang polysaccharides (SHP) and MXene respond to both acidic environments and NIR to reduce bacterial burden and scavenge ROS [170]. The most advanced approaches move beyond conventional drug delivery. Biomechanical systems utilize in situ triggered self-contraction of core-shell microgel assemblies to physically pull wound edges together, actively promoting wound closure and tissue regeneration in diabetic mice [171]. “Living” microgel dressings, such as hierarchically encapsulated probiotic microgel systems (macrogel/microgel/biofilm), secrete sustained, adaptive probiotic metabolites to resolve infection and modulate inflammation without inducing antibiotic resistance [172]. While these highly complex systems demonstrate immense therapeutic potential in overcoming diabetic wound stagnation, their intricate designs present significant hurdles. Architectural and stimuli-responsive systems must be robust enough to function in highly exudative environments, while living probiotic materials face massive challenges regarding manufacturing scalability, long-term storage stability, and navigating the rigorous regulatory approval process required for live biotherapeutics. Pancreatic tissue engineering For treating type 1 diabetes, composite microgels are primarily used to create bioartificial pancreas constructs. The central goal is to provide mechanically stable, immunoprotective, and bioactive microenvironments for encapsulated islets or β-cells, enabling long-term, glucose-responsive insulin secretion while shielding them from immune attack. For whole pancreatic islets, the key objective is to preserve native endocrine architecture while preventing allogeneic rejection. Initial strategies rely on passive immunoisolation, using biodegradable, partially oxidized alginate microgels [173] or CMC-coated chitosan microgels [174] to create simple physical barriers that support long-term diabetes management. Core-shell architectures further decouple immune exclusion from mass transport. PEGDA and alginate shells block immune components while permitting sufficient nutrient exchange to normalize glucose levels in diabetic rats [175]. However, passive barriers alone cannot address a major cause of islet failure, which is acute hypoxia and poor vascular engraftment post-transplantation. Consequently, more advanced constructs incorporate active support functions. For example, co-transplanted nanocomposite and oxygen-generating microgels suppress inflammation by covalently bonded rapamycin in cyclodextrin NPs while mitigating hypoxia through in situ oxygen generation [137]. Beyond individual encapsulation, islet-laden microgels can be assembled into macroscopic bioartificial pancreas constructs that better recapitulate native pancreatic microarchitecture. As illustrated in Fig. 6D, microencapsulation of islets in anti-adhesive core-shell microgels followed by macroencapsulation in a prevascularized hydrogel scaffold synergistically combines immune-isolating zwitterionic shells with VEGF-driven vascular niches. This hierarchical assembly significantly enhances islet survival and insulin secretion, maintaining normoglycemia in diabetic mice for at least 90 days without systemic immunosuppression [44]. Furthermore, time-sequential assembly of islets-laden microgels creates injectable and retrievable constructs, enabling minimally invasive and reversible therapy [176]. Despite these advances, clinical translation of whole-islet encapsulation remains severely constrained by donor scarcity and variability of isolated islets. To address donor limitations, a second approach focuses on encapsulating β-cells or stem-cell-derived β-like cells, offering a highly scalable cell source. Here, composite microgels must go beyond immunoprotection to actively support self-assembly and functional maturation. Thin-shelled hollow PEG-TA microgels provide immunoisolated voids that allows encapsulated β-cells to spontaneously self-assemble into insulin-secreting spheroids [24]. Alternatively, porous GelMA-based composite microgels co-encapsulate β-cells with MSCs to enhance nutrient and insulin transport and promote beneficial paracrine support. MSCs co-culture provides critical immunomodulatory and anti-apoptotic support that collectively improve β-cell survival and glycemic control in diabetic mice [177]. Comparing these approaches highlights a clinical trade-off. β-cell encapsulation alleviates donor scarcity, but engineered β-cell spheroids often do not fully match the rapid, dynamic insulin secretion kinetics of native islets. Future translation will therefore require microgel designs that not only provide immunoprotection but also promote long-term maturation and rapid glucose-sensing functionality. Applications in other tissues While bone, cartilage, skin, and pancreas represent the major areas for composite microgels, their versatility extends to a range of other tissues. As targets become more complex, design requirements shift from providing structural support to enabling multicellular vascularization, metabolic stabilization, and electroactive connectivity. For vascularized tissues, a key challenge is establishing sufficient perfusion before ischemic necrosis occurs. In vascularized endodontic regeneration, composite microgels can promote vasculogenesis by enforcing spatial proximity between distinct cell populations. For example, co-encapsulation of HUVECs and hDPSCs in GelMA/Alg microgels facilitates robust proliferation and 3D capillary network formation. This spatial proximity enhances osteogenic and odontogenic differentiation, promoting superior microvessel formation in an immunodeficient nude mouse model [178]. Likewise, in breast reconstruction, ADSCs encapsulated in laminin-modified alginate microgels containing ginsenoside Rg1 demonstrate enhanced angiogenesis and adipogenesis. When co-implanted with autologous adipose tissue, these systems exhibit potential for effective breast tissue engineering [22]. Translationally, such highly vascularized constructs require balancing microgel degradation to permit vessel infiltration with sufficient long-term mechanical stability to maintain tissue volume. Beyond structural tissues, composite microgels are increasingly employed to engineer highly metabolic organs such as the liver, where a major clinical hurdle is rapid loss of hepatocyte function in vitro. Self-assembly of stem cell-laden GelMA/HAMA microgels incorporating Au nanoclusters-miRNA complexes creates bioengineered liver microtissues. They support rapid hepatic differentiation and provide antioxidative, anti-inflammatory, and pro-angiogenic functions, enabling functional rescue in acute liver failure models [72]. This microgel approach provides immediate, localized biochemical cues that stabilize the fragile metabolic phenotype of the cells, which bulk hydrogels often fail to achieve due to mass transport limitations. Neural tissue applications impose some of the most demanding requirements, combining spatial organization with functional electroactivity. In peripheral nerve repair, injectable lipoic acid/gelatin microgels can work synergistically with a nerve guidance conduit and hydrogen-releasing magnesium coils to reconstruct a pro-regenerative microenvironment. Sustained hydrogen release reduces oxidative stress and inflammation, while electrical stimulation and microgel filling promote angiogenesis, neurotrophic factor expression, and mitochondrial function [179]. Extending architectural control further, human induced pluripotent stem cells (hiPSCs) encapsulated in core-shell microgels can be positioned and fused in a multilayer microfluidic chip to assemble region-specific brain organoids (cortical, thalamic, hippocampal) into neural tissues with active migration, synaptic connectivity, and coordinated calcium signaling [180]. Despite these advances, translation remains constrained by the difficulty of achieving long-term functional and electrophysiological integration with host neural circuits. Across these diverse examples, a unifying advantage of composite microgels is their ability to create localized, multifunctional microenvironments that single-component systems typically cannot provide. As composite microgels are extended to emerging areas such as cardiac patches, kidney organoids, and retinal repair, clinical impact will depend on scaling microscale precision to manufacturable, reproducible constructs while maintaining long-term tissue function in vivo. Emerging applications in bioelectronics Beyond therapeutic delivery and regeneration, composite microgels are also emerging as critical materials for bioelectronics. Conventional bioelectronic interfaces often suffer from mechanical mismatch with soft tissues, while bulk conductive hydrogels struggle with injectability and high-resolution printability. Conductive composite microgels address these limitations by integrating electrical function with shear-thinning mechanics, supporting soft, flexible, and printable electronic systems. Designing conductive microgels generally involves a trade-off between electrical performance and biosafety. Metal-based fillers provide high conductivity and field responsiveness. For instance, liquid metal microgels become conductive under microstrain, pressing, and freezing, making them highly adaptable for flexible electronics and wearable electronic clothing [181]. For internal applications, HA microgels embedded with in situ reduced AgNPs form conductive granular hydrogel that maintain high conductivity while remaining printable for electroactive tissue support [59]. However, metal-based systems raise translational concerns, including long-term in vivo toxicity, potential nanoparticle leaching, and oxidative degradation. An alternative approach uses intrinsically conductive polymers. For instance, alginate microgels incorporating poly(3,4-ethylenedioxythiophene):poly(styrenesulfonate) (PEDOT:PSS) provide a metal-free platform that is conductive, injectable, and compatible with 3D printing, with improved biocompatibility [182]. Despite early progress, major engineering challenges remain. A key hurdle is maintaining a stable percolation network as microgels swell, degrade, and undergo cyclic mechanical loading in vivo. Long-term success will require electrical stability without compromising mechanical compliance and biocompatibility needed for chronic tissue integration. Challenges and future perspectives Composite microgels offer an exceptionally broad design space that integrates multi-material composition, crosslinking chemistry, architecture (e.g., core-shell/hollow/multicompartment), and assembly. These parameters can be jointly engineered to combine intrinsic cues (mechanics/biochemistry/structure) with dynamic regulation (stimuli-responsiveness and pre-programmed kinetics) for biomedical applications spanning cancer therapy and regenerative medicine. However, the same features that enable advanced therapeutic functions also create a coupled translational bottleneck. Increasing architectural and functional sophistication intensifies difficulties in manufacturing consistency, biosafety and clearance validation, and clinical integration. Addressing these challenges therefore requires treating scalability, safety, and usability not as downstream hurdles, but as fundamental design constraints considered alongside biological function from the early stages of development. Scalability and quality control of complex architectures One of the major hurdles for the clinical translation of composite microgels is the trade-off between production scale and particle-level consistency, which can be viewed as a precision-throughput trade-off that becomes more severe as architectural complexity increases. Scaling the production of simple, homogeneous microgels is comparatively feasible using traditional batch emulsion or related high-throughput methods. In contrast, heterogeneous composite architectures depend on spatial segregation fidelity (compartment size, boundary integrity, and interfacial chemistry), which is still most reliably achieved with low-throughput microfluidic approaches. Transitioning these designs to scalable routes (e.g., gas shearing [28] or PPAP [101]) is promising, but introduces a central risk because higher throughput can come at the expense of compartment precision and increased batch-to-batch variability. Consequently, establishing mechanistically grounded CQAs becomes essential for translation. In practice, this requires defining CQAs that are directly linked to the intended functional mechanism and target clinical application, and quantifying them using characterization methods that capture particle-to-particle and batch-to-batch variability. Examples include single-particle mechanical property distributions, which are decisive for mechanotransduction-driven outcomes and immune cell activation (e.g., stiffness-dependent T cell responses) [52]; shell permeability and thickness uniformity, which determine glucose/insulin exchange and immunoisolation performance in islet/β-cell encapsulation [24,44]; and intraparticle spatial distribution of nanomaterials or bioactive agents, which can govern multi-stimuli release fidelity and combined effects in cancer therapy [25,60]. Advancing composite microgels toward clinical translation will require linking scalable fabrication with scalable characterization, such as nano/microstructure inspection at high resolution [183], and high-throughput mechanical measurements of single microgel by fluidic force microscopy [184]. This integration ensures that architectural fidelity and functional consistency are verified as part of routine quality control rather than inferred retrospectively from small-batch performance. Biosafety, degradation byproducts, and immunogenicity The compositional complexity of composite microgels raises specific biosafety concerns beyond those of single-component microgels. A key unresolved challenge is the long-term in vivo fate of incorporated nanomaterials, such as AuNPs and SPIONs used for photothermal or magnetothermal functions. As the polymer network degrades, these components may be released and redistributed, requiring evaluation of their in vivo distribution, persistence, and clearance over clinically relevant timescales. Clearance is strongly influenced by nanoparticle size and surface chemistry. Ultrasmall AuNPs have been reported to exhibit higher renal clearance [185], whereas larger particles more often accumulate in the liver and spleen [186]. Accordingly, composite designs intended for systemic or long-term applications must minimize non-degradable nanomaterial, optimizing the size and surface chemistry of essential inorganic components to facilitate efficient physiological clearance. A second, frequently overlooked challenge is the complex degradation profile of composite microgels, which can yield a mixture of byproducts with composition and release kinetics fundamentally distinct from single-component systems. The critical toxicological concern extends beyond the safety of individual byproducts to encompass potential combinatorial interactions that single-component testing cannot predict. Consequently, safety evaluations must prioritize the composite-specific degradation profile by characterizing the chemical composition, release kinetics, and clearance of all byproducts to ensure the absence of persistent local inflammation. This necessitates the development of integrated, composite-specific safety testing frameworks to complement and, where appropriate, replace conventional component-by-component assessments. The immunogenicity of composite systems represents a third critical translational hurdle. As highlighted throughout this review, many functional strategies rely on engineered interfaces, such as adhesive or protein-adsorbing coatings (Section 3.1.2), charged shells (Section 2.2.2), and biologically active components in living composites (Section 4). In long-term implantable or encapsulation applications, these features can improve retention, cell interaction, and therapeutic potency, but may also increase the risk of immune recognition, foreign body responses, and fibrotic encapsulation (a known challenge in islet encapsulation). Importantly, different surface engineering strategies carry distinct immunogenic profiles that should be evaluated comparatively. For example, protein-adsorbing coatings (e.g., PDA [125]) can increase non-specific protein adsorption and potentially alter host immune recognition, and charge-bearing multilayers (e.g., LBL shells [96]) may introduce charge-dependent biointerfacial interactions. Future biosafety evaluations must therefore utilize immune assays and in vivo models matched to the intended clinical application, carefully distinguishing between local injectable formulations and macroscopic implants, as well as short-term therapies and long-term tissue integration. By explicitly linking these immune outcomes to controllable CQAs, such as surface chemistry, charge density, and degradation kinetics, researchers can establish iterative, predictive design cycles rather than relying on retrospective biocompatibility screening. Clinical integration, sterilization, and regulatory-commercial pathway Beyond scalable manufacturing and validated biosafety, successful translation of composite microgels requires seamless integration into established clinical workflows. This necessitates addressing stringent practical constraints, including sterilization protocols, formulation stability, and delivery device compatibility. The micrometer scale dimensions of these particles preclude standard sterile filtration, whereas terminal sterilization methods such as autoclaving or gamma irradiation frequently compromise the precise structural and chemical features that confer therapeutic function, inducing the cleavage of covalent crosslinks, the disruption of stimuli-responsive domains, and the denaturation of encapsulated biologic therapeutics. This motivates two complementary engineering strategies. The first involves developing sterile-by-design manufacturing pipelines utilizing closed, aseptic processing for highly sensitive architectures. The second requires the rational selection of materials and crosslinking chemistries inherently resilient to clinically deployable sterilization methods, while preserving CQAs. Notably, several composite formulations discussed in Section 4.2 already incorporate radical-scavenging components, such as CeO2 microspheres, PDA, and tannic acid derivatives, to provide therapeutic antioxidant functions in vivo. We hypothesize that this inherent radical-scavenging capacity could be deliberately leveraged to mitigate radiation-induced polymer chain scission during gamma sterilization. Systematically validating this dual-function design strategy, which utilizes these components for both physiological ROS management and manufacturing radioprotection, represents a highly translational and underexplored direction for advancing clinical feasibility. Beyond sterilization, formulation stability and delivery device compatibility impose equally critical translational constraints. To ensure a commercially viable shelf-life, injectable microgels must remain stable as homogeneous suspensions over extended storage periods. However, these suspensions are inherently vulnerable to degradation through aggregation, polymer breakdown, or nanoparticle leaching, which can compromise CQAs over time. While lyophilization can extend storage stability, it introduces additional manufacturing complexity and cost, and the reconstitution process must be rigorously validated to confirm that the microgel architecture and functional properties are fully recovered. Upon administration, these formulations must reliably pass through clinically relevant needles and catheters without clogging. This rheological requirement is particularly challenging for non-spherical microgels, such as the rods and polygons discussed in Section 2.2.1. While these anisotropic architectures provide distinct biological advantages, including directional topographical cues and enhanced tissue penetration, their irregular geometries significantly increase the risk of entanglement and jamming under the shear forces of clinical injection. For such systems, successful translation necessitates the concurrent development of specialized delivery devices and advanced formulation strategies. Rather than relying on simple liquid suspensions, researchers may leverage the assembly techniques discussed in Section 2.3, organizing the irregular particles into jammed or dynamically crosslinked granular hydrogels. Therefore, treating formulation stability and injectability as fundamental design parameters, rather than retrospective engineering challenges, is essential for preserving the clinical utility of these advanced architectures. In addition to these practical constraints, composite microgels face a regulatory and commercial pathway that is qualitatively more demanding than that of simpler systems. A review of clinical trial registries on ClinicalTrials.gov reveals that the microgel systems are currently in clinical trials, such as the safety and efficacy of DEB-TACE with visualizable embolization microgels or polyvinyl alcohol microgels for hepatocellular carcinoma. Completed evaluations of gelatin or tris-acryl gelatin microgels for uterine artery embolization in symptomatic fibroids, as well as drug-eluting microgels for targeted chemoembolization, highlight that compositional simplicity enables a straightforward regulatory pathway. Multi-stimuli composite microgels, by contrast, rely on highly coordinated biological and chemical mechanisms that regulatory agencies evaluate with significantly greater stringency. The most viable translational strategy is therefore a modular complexity approach. Researchers should begin with composite designs that add a single functional component to an already approved platform, establish safety and efficacy for this incremental advance through clinical data, and use that regulatory clearance to justify progressively more complex architectures. This mirrors a broader established pathway of incremental, evidence-based complexity escalation in biomedical devices, demonstrating how stepwise advances can successfully navigate demanding regulatory environments. From a commercialization perspective, combining multiple polymers, nanomaterials, and bioactive agents frequently creates overlapping patent claims. This fragmented intellectual property (IP) landscape makes licensing negotiations complex and financially burdensome for translational startups. Researchers developing composite microgels with translational intent should therefore engage in IP strategy early, prioritizing compositional designs that utilize materials with expired or broadly licensed IP or generate sufficiently novel composite architectures to establish clean proprietary positions. Future perspectives: towards intelligent, translatable composite microgels Progress in the field of composite microgels will be accelerated by a paradigm shift from maximizing functional complexity to optimizing application-specific utility, guided by quantitative CQAs. Two near-term priorities emerge from the translational challenges discussed above. First, the field urgently requires standardized reporting of composite microgel CQAs that directly map to the regulatory mechanisms emphasized in Sections 3. These metrics must include distributions of stiffness and viscoelasticity at the single-particle level, compartment fidelity metrics, permeability measures for core-shell architectures, and release testing under physiologically relevant conditions. Establishing such standardization will improve cross-study comparability and support reproducible translation efforts. Second, integrating scalable fabrication methods, such as gas shearing or PPAP, with high throughput quality assurance readouts will be critical for advancing complex architectures beyond the proof-of-concept stage. In parallel, data-driven design will become increasingly vital as the compositional and architectural design space expands. The impact of machine learning (ML) and artificial intelligence (AI) will be most significant when targeted at the specific CQAs and manufacturing bottlenecks identified in this section. Rather than replacing mechanistic understanding, ML and AI approaches are most powerful when trained on datasets that explicitly link formulation and processing parameters to critical structural outputs, including stiffness distributions, compartment fidelity, shell permeability, and degradation profiles. This data-driven approach enables a more efficient navigation of the complex trade-offs among manufacturability, biological function, and biosafety, thereby accelerating convergence toward validated, clinically viable designs. As recently demonstrated, an AI-assisted framework can establish a phase diagram and a predictive model to rationally design microgels with programmable properties for in situ forming scaffolds [187]. While it supports this direction, realizing their broader impact will depend on the establishment of consistent data structures and function-driven target properties relevant to specific clinical applications. Ultimately, composite microgels are best positioned for clinical translation when their engineered sophistication is explicitly tied to a therapeutic mechanism that simpler, single-component systems cannot deliver. This includes capabilities such as spatiotemporally staged signaling (Section 3.2.2), microenvironmental targeting via multi-stimuli integration (Section 3.2.1.4), or modular assembly into tissue-scale constructs (Section 2.3). Furthermore, this added architectural complexity must be matched by equivalent control over CQAs, rigorously validated biosafety profiles, and clinically compatible manufacturing and delivery pathways. By treating scalability, biosafety, and clinical integration as fundamental design constraints from the outset rather than downstream translational hurdles, the next generation of composite microgels can evolve from highly engineered laboratory platforms into transformative tools for medicine, regenerative therapies, and next-generation healthcare solutions. CRediT authorship contribution statement Yanli Cai: Conceptualization, Visualization, Writing – original draft. Dong Xu: Visualization, Writing – original draft. Zi En Chong: Visualization. Elaine Shi An Chen: Writing – original draft. Soo Wah Gan: Writing – original draft. Alvin Shu Kiat Bok: Writing – original draft. Wen Feng Lu: Supervision, Writing – review & editing. Wei Zhai: Supervision, Writing – review & editing. Ching-Chiuan Yen: Supervision, Writing – review & editing. Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.